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ABSTRACT

Epilepsy is one of the most common neurological disorders in children, with both seizures and
their medical treatment associated with increased risk of neuropsychological impairments.
Adaptive functioning in children with epilepsy is poorly understood. This study sought to identify
the neuropsychological and medical predictors of optimal adaptive functioning in pediatric
epilepsy. Forty-six children with epilepsy and 16 typically developing children and their parents
participated in this study at two time points. Overall, adaptive functioning was found to be in the
average to low average range in children with epilepsy. A composite measure assessing
cumulative seizure history was able to significantly predict Adaptive Behavior Assessment
System-II (ABAS-II) scores. Whether a child had experienced one or more seizures in the last
year was the only individual seizure and treatment variable able to significantly predict adaptive
functioning as measured by the ABAS-II. Verbal learning, executive functioning, and
internalizing and externalizing behavior problems assessed at Time 1 predicted performance on
the ABAS-II at Time 2. Verbal memory and attention, however, were not significant predictors
of adaptive functioning. Consistent with what was hypothesized, executive functioning was
found to mediate the relationship between seizure history and adaptive functioning when

controlling for behavior problems at both Times 1 and 2. When behavior problems were the
mediator and executive functioning was controlled for, mediation was not found. Executive
functioning also mediated the relationship between group membership (monotherapy,
polytherapy, and typically developing) and ABAS-II scores at Time 1, but not at Time 2 when a
post-surgical group also was represented. Secondary analyses showed that the relationship
between executive and adaptive functioning at Time 2 was moderated by whether or not a child
had ever experienced seizures, such that children diagnosed with epilepsy evidenced greater
correlations between these constructs than typically developing children. The results of this
study suggest that a subset of children with epilepsy, those with active seizures and/or
executive dysfunction, are at increased risk of adaptive deficits. These findings highlight the risk
factors for suboptimal adaptive functioning in this population, and also suggest potential
avenues for remediation.

INDEX WORDS: Epilepsy, Pediatric, Adaptive functioning, Epilepsy surgery,
Neuropsychological functioning

MEDICAL AND NEUROPSYCHOLOGICAL PREDICTORS OF ADAPTIVE FUNCTIONING IN
CHILDREN WITH EPILEPSY

by

AIMILIA PAPAZOGLOU

A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of

Doctor of Philosophy

in the College of Arts and Sciences

Georgia State University

2010

Copyright by
Aimilia Papazoglou
2010

MEDICAL AND NEUROPSYCHOLOGICAL PREDICTORS OF ADAPTIVE FUNCTIONING IN
CHILDREN WITH EPILEPSY

by

AIMILIA PAPAZOGLOU

Committee Chair: Tricia Z. King

Committee: Thomas G. Burns
Christopher Henrich
Robin D. Morris

Electronic Version Approved:

Office of Graduate Studies
College of Arts and Sciences
Georgia State University
May 2010

iv

For Mum
With love and gratitude

v
ACKNOWLEDGEMENTS

There are so many people I would like to thank for helping me reach this milestone.
Firstly, I am grateful to my advisor and dissertation chair, Dr. Tricia King, for her advice, support,
and friendship throughout my time at Georgia State University. I am immensely proud to have
been one of your students. I would also like to thank the members of my committee, Dr. Thomas
Burns, Dr. Chris Henrich, and Dr. Robin Morris for generously sharing your time and expertise
over the years. I have learned so much from all of you. I thank the children and their families
who gave of their time to participate in this study. This work was supported by grants from
Georgia State University and the American Psychological Foundation and the Council of
Graduate Departments of Psychology.
Thank you to the members of the King Lab, especially Matthew Mumaw and John Ryan,
for never letting me take myself too seriously, and for keeping me on my toes with an, at times,
unyielding string of pranks. I would like to thank my grandfather, Phillip Asher, for always
believing in me, and I am sorry you are not here to celebrate this with me. I would like to thank
my family and friends for their love and encouragement. Dad, thank you for your support and for
helping to spark my interest in all things neurological. Evi, thank you for keeping me sane during
this process, and reminding me that there is little that is more important in life than spending
time with the people you love and good food. Mum, I thank you for everything.

vi
TABLE OF CONTENTS
ACKNOWLEDGEMENTS

v

LIST OF TABLES

viii

LIST OF FIGURES

ix

CHAPTER
1

2

3

INTRODUCTION

1

Animal Models of Epilepsy

2

Seizure Types

3

Treatments for Epilepsy

5

Antiepileptic Drugs

5

Effects of Epilepsy on Neuropsychological
Functioning

9

Age at Seizure Onset

16

Time Elapsed since Epilepsy Diagnosis

18

Surgical Intervention for Epilepsy

20

Infrequent Use of Comparison Groups

29

The Current Study

31

Specific Aims

33

METHOD

34

Participants

34

Experimental Design

58

Measures

59

RESULTS
Primary Analyses

67
73

vii

Supplementary Analyses
4

DISCUSSION

85
88

Specific Aim 1

93

Specific Aim 2

97

Supplementary Analyses

100

Remediation of Adaptive Functioning Deficits

103

Limitations

106

Future Research

106

Conclusions

108

REFERENCES

110

APPENDICES

124

A

SEIZURE HISTORY SCALE

124

B

SEIZURE INFORMATION FORM SENT TO PARENTS
FOR COMPLETION

126

viii
LIST OF TABLES
Table 1:

Means (standard deviations) and frequencies for children who
participated in the study and those who did not at Time 1.

41

Table 2:

Demographic information according to group at Time 2.

45

Table 3:

Names of current Antiepileptic Drugs (AEDs), number of past
AEDs, and seizure types at Time 2 according to group membership.

48

Table 4:

Mean neuropsychological performance in standard scores across
groups and percentage below normal.

52

Table 5:

Significant differences between groups on neuropsychological
measures at Time 1 and Time 2 according to t-tests.

55

Table 6:

Correlation matrix between seizure and treatment variables at Time
2 and adaptive functioning.

68

Table 7:

Correlation matrix for variables at Time 1.

69

Table 8:

Correlation matrix for variables at Time 2.

70

Table 9:

Correlation matrix between variables at Time 1 and Time 2.

71

Table 10:

Unstandardized b coefficients (standard error) showing the ability of
seizure variables to predict the three domains of the ABAS-II.

75

Table 11:

Unstandardized b coefficients (standard error) showing the ability of
neuropsychological variables to predict the three domains of the
ABAS-II.

77

Table 12:

Coefficients (standard errors) for mediation with the Seizure History
Scale (SHS) as the Independent Variable at either Time 1 or Time 2
(both when Time 1 scores on the SHS are controlled for and when
they were not).

80

Table 13:

Coefficients (standard errors) for mediation with Group as the IV at
either Time 1 or Time 2 (both when Time 1 group membership is
controlled for and when it was not).

83

ix
LIST OF FIGURES
Figure 1a:

Mediational model examining executive functioning or behavior
problems at Time 1 as a mediator of the relationship between the
Seizure History Scale at Time 1 and adaptive functioning at Time 2.

35

Figure 1b:

Mediational model examining executive functioning or behavior
problems at Time 2 as a mediator of the relationship between the
Seizure History Scale at Time 2 and adaptive functioning at Time 2.

36

Figure 2a:

Mediational model examining executive functioning or behavior
problems at Time 1 as a mediator of the relationship between
Group at Time 1 and adaptive functioning at Time 2.

37

Figure 2b:

Mediational model examining executive functioning or behavior
problems at Time 2 as a mediator of the relationship between
Group at Time 2 and adaptive functioning at Time 2.

38

Figure 3:

Bar graph showing the differences in adaptive functioning according
to whether seizures are active (n = 26 ) or controlled (n = 20).

76

Figure 4:

Regression lines for the relationship between executive functioning
and adaptive functioning as moderated by whether children have
epilepsy or are typically developing (a 2-way interaction).

86

1
Chapter 1
INTRODUCTION
One percent of the population under 20 years of age will develop epilepsy and it is one
of the most common neurological conditions in children (Epilepsy Foundation, n.d.). Children
and young adults are particularly susceptible to epilepsy, with more than 50% of all cases
beginning before the age of 25. Epilepsy is diagnosed when a person has two or more seizures,
which are short bursts of electrical activity in the brain typically lasting a few seconds or
minutes. Seizures have many symptoms ranging from convulsions to loss of consciousness to
blank staring. Antiepileptic drugs (AEDs) are the most common treatment for epilepsy and exert
their therapeutic effects by decreasing the brain’s sensitivity to this electrical activity. On a single
AED, 60 to 88% of children are seizure-free at 12 months with differences in the success rates
due to AED and patient specific variables such as the AED used and its dose as well as patient
age and genetic background (Glauser et al., 2006). The chance of obtaining freedom from
seizures after one AED has failed is about 30%, and this number declines to less than 5% after
failure with three AEDs (Sheth et al., 2000). In a small number of children, seizures will remit
spontaneously with a rate of 4% in children with normal intelligence, and of 1.5% in children with
mental retardation (Huttenlocher et al., 1990). Surgical intervention may be considered for the
20-30% of children whose seizures are not adequately controlled by medication. Of those
children determined to be good surgical candidates, as many as 70% may be seizure free
following surgery (Duchowny et al., 1992; Kim et al., 2000; Wyllie, 1998).
Seizures are symptoms of abnormal brain function. With the exception of very young
children and the elderly, the cause of seizures is often not known. It is estimated that a cause
cannot be found for approximately 70% of patients with epilepsy (Epilepsy Foundation, n.d.).
These patients are labeled as having either cryptogenic (seizures presumed to be symptomatic
without a genetic or other identified cause) or idiopathic (seizures presumed to be genetic in
origin) epilepsy. For the 30% of cases where a cause can be identified, etiologies include lack of
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oxygen during birth, head injuries, brain tumors, genetic conditions, febrile seizures, lead
poisoning, cortical malformations (also known as cortical dysplasias), and infections such as
meningitis or encephalitis. These patients are identified as having symptomatic epilepsy.
A diagnosis of epilepsy has not only immediate, but also lifetime, consequences for
cognitive, psychological, adaptive, and social functioning. Seizures and their treatment are
believed to have adverse effects on child development, with intractable seizures being
especially detrimental. Children with epilepsy are frequently found to have below average
cognitive performance as well as poorer academic achievement compared to typically
developing peers. Impairments in memory and attention as well as mental slowing are most
commonly reported. Many studies report more widespread impairments. For example, Bailet &
Turk (2000) found that children with epilepsy scored significantly lower than sibling controls on
measures of intelligence, psychomotor speed, memory, academic achievement, and behavior,
and that these deficits persisted over time.
The presence of seizures during childhood may affect brain development. Many factors
are believed to influence the functional integrity of the developing brain in children with epilepsy
and these include cumulative seizure burden (e.g. seizure frequency, duration of epilepsy,
incidence of status epilepticus), the underlying pathophysiologic substrate(s), comorbidities, age
at onset, neuropsychological impairment, chronic AED therapy, and genetic makeup (e.g.,
susceptibility of seizure-induced brain injury, pharmacogenetics; Sankar & Rho, 2007). In the
presence of such a multitude of factors that can affect the functional integrity of the brain and
the difficulty of controlling for these potentially confounding factors, researchers have turned to
animal models to better establish whether seizures negatively affect brain development (Sankar
& Rho, 2007).
Animal Models of Epilepsy
Animal models of epilepsy are widely used to better understand the processes leading to
epilepsy and to identify drug targets for antiepileptogenesis (Loscher, 2002b). Although more
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research is needed, there is evidence that both recurrent seizures and status epilepticus may
affect the developing brain. They may do so in many ways ranging from injury and altered
neurogenesis to plasticity leading to epileptogenicity and behavioral and cognitive impairments
even without the presence of readily discernable injury (Sankar & Rho, 2007). For example, in
rat pups injected with kainic acid, an excitatory neurotoxin, short and long-term spatial memory
abilities were lower than those of control rat pups, even without the presence of discernible
neuronal injury (Sayin et al., 2004). Ten mg/kg of kainic acid can induce seizures in adult rats
that are severe and produce hippocampal damage similar to that of mesial temporal sclerosis,
while a dose of 3mg/kg of kainic acid administered to 15 day old rat pups (they cannot survive a
dose of 10mg/kg), produces severe seizures, but no discernable hippocampal damage. When
these same rat pups, however, were exposed to kainic acid again at 45 days they evidenced
more severe brain damage and poorer performance on spatial learning tasks than rats that were
only exposed to kainic acid at 45 days (Sankar & Rho, 2007). Animal models also have shown
that inflammation amplifies seizure-induced injury (Sankar & Rho, 2007), which is consistent
with human literature showing hippocampal signal changes on MRI in children who have
experienced prolonged febrile seizures (Shinnar et al., 2005). These findings and others using
animal models of epilepsy suggest that cognitive deficits may be present even in the absence of
overt neuronal damage, that the genesis of neuronal damage following seizures may vary
according to brain maturity, and that the experience of prior seizures may alter the impact of
subsequent seizures.
Seizure Types
There are many different types of seizures; each of which may have different causes
and symptoms. Patients may experience only a single type of seizure or multiple types of
seizures. The 1981 classification system of the International League Against Epilepsy (ILAE) is
used in many institutions around the world, and although it has its detractors it is still the most
commonly used classification system (Engel, 2006; ILAE, 1981). According to this classification
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system, there are two broad categories of seizures: partial seizures, which, at least initially, start
in one area of the brain and generalized seizures, which involve the entire brain.
Partial seizures may also be known as focal or local seizures and can be subdivided into
three groups. Simple partial seizures usually have unilateral hemispheric involvement, and
consciousness is not impaired. Complex partial seizures frequently have bilateral hemispheric
involvement, and consciousness is impaired. Both simple and complex partial seizures may
occur with motor signs, with somatosensory symptoms, with autonomic symptoms or signs, or
with psychic symptoms such as detachment, memory or time distortion, or unprovoked emotion.
The third type of partial seizures are those that are secondarily generalized and may begin as
either simple or complex partial seizures.
There are six types of generalized seizures. Absence seizures are characterized by brief
episodes of staring, during which awareness and responsiveness are impaired. They may also
involve mild clonic, tonic, or atonic components as well as automatisms. Atypical absence
seizures are similar, but changes in motor tone are more pronounced, they last longer, and
onset and resolution is typically more gradual. Myoclonic seizures involve the sudden jerking of
extremities. Seizures with tonic and/or clonic manifestations are marked by unconsciousness,
convulsions, and muscle rigidity, with clonic seizures characterized by repetitive jerking
movements and tonic seizures by muscle stiffness and rigidity. Eye blinking or slight jerking
movements of the mouth may occur. Atonic seizures are marked by a loss of muscle tone.
There are other types of seizures that do not fit into the above categories. Status
epilepticus is defined as a single continuous seizure (or recurrent seizures between which the
patient does not regain consciousness) that show no signs of stopping after a duration that
encompasses the majority of seizures of that type in most patients. This duration is usually
defined as 30 minutes of uninterrupted seizure activity, however, it is recommended that
medical assistance be sought if a seizure continues for more than 5 minutes. It is estimated that
as many of 15% of people with epilepsy will experience status epilepticus at least once
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(Epilepsy Foundation, n.d.). Gelastic seizures are marked by inappropriate laughter and may be
followed by eye or head movements, automatisms, and altered awareness. Although not part of
the ILAE’s classification system, psychogenic seizures may also occur. These events look
similar to epileptic seizures, although some may appear different from typical epilepsy
presentations. Psychogenic seizures are thought to be caused by subconscious mental activity
rather than abnormal electrical activity. They are considered to be psychological in origin, but
are typically not purposefully produced.
Treatments for Epilepsy
The most common treatment for epilepsy is antiepileptic drugs (AEDs). Other treatment
options include surgical removal of the epileptogenic focus, vagal nerve stimulation, and the
ketogenic diet. The use of AEDs and surgical intervention are a focus of this paper and will be
discussed in subsequent sections. Vagal nerve stimulation is an alternative treatment typically
considered when surgical resection is not feasible or has been unsuccessful (McHugh et al.,
2007). It involves electrical stimulation of the vagal nerve in the neck to reduce the frequency
and severity of seizures. How it exerts its therapeutic effects is not well understood, but it is
believed to prevent the hypersynchronization of neuronal activity (McHugh et al., 2007). The
ketogenic diet is a strict diet of high fat, low protein, and low carbohydrate foods. Although the
exact mechanism of its therapeutic benefit also is unclear, it is believed to provide seizure
control by inducing a state of ketosis (Casey et al., 1999), which is a physiological state
associated with chronic starvation where ketone bodies rather than glucose are the body’s
source of energy.
Antiepileptic Drugs
The goal of treatment with AEDs is to reduce seizure frequency and enhance quality of
life with as few side effects, co-medications, and long-term detrimental effects as possible. A
majority of neurologists recommend waiting until after a child has had a second seizure before
beginning AED therapy in order to ascertain that pharmacotherapeutic intervention is necessary
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(Miller & Drislane, 2007). There are, however, times when the risk of recurrent seizures is higher
(such as with a tumor or infection) and immediate AED treatment may be warranted. In children
who have experienced a single unprovoked afebrile seizure, this risk of seizure recurrence has
been found to range from 29% to 46% at one year and 37% to 54% at two years, with most
recurrences happening within the first 6 months (Shinnar et al., 1996; Stroink et al., 1998). Once
a second seizure has occurred, the risk of recurrence is greater and treatment with AEDs is
typically warranted (Miller & Drislane, 2007).
AEDs are designed to reduce or remove abnormal discharges in the brain, however, the
actual neurochemical bases of epileptogenic discharges are not well understood. Enhanced
excitatory amino acid transmission, impaired inhibitory transmission, and abnormal electrical
properties of affected neurons have all been implicated (Rang et al., 1995). AEDs act by
increasing inhibition in the brain in order to prevent or reduce seizure activity. This can be done
in a number of different ways. AEDs are typically grouped according to their main effect,
although many are capable of multiple effects. These include sodium channel blockers, calcium
current inhibitors, GABA enhancers, glutamate blockers, carbonic anhydrase inhibitors, and
hormones. There are also AEDs whose mechanism of action is not currently well understood. A
single AED may increase inhibition in the brain by multiple methods, and those that do so tend
to be more effective against a broad range of seizure types. The two most common
mechanisms of action are the enhancement of GABA and inhibition of sodium channel function
(Rang et al., 1995). GABA activity may be enhanced by facilitating GABA-mediated opening of
chloride channels (e.g., Phenobarbital, Benzodiazepines) or by inhibiting the enzyme that
inactivates GABA (e.g. Valproate (Depakene), Vigabatrin). AEDs that block sodium channels
typically do so by preventing the channels from returning to an active state following an action
potential (e.g., Phenytoin (Dilantin), Carbamazepine (Tegretol)).
Over the last few decades, there have been advances in the pharmacotherapeutic
treatment of epilepsy with the introduction of several new AEDs and the reformulation of several
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older AEDs (Loscher, 2002a). These newer AEDs are not necessarily more efficacious, but
appear to be safer, better tolerated, and have fewer interactions with other medications
(Malphrus & Wilfong, 2007). Animal models of chronic epilepsy, including the kindling model of
temporal lobe epilepsy and the post-status epilepticus model, are widely used to test the
efficacy AEDs. Current pharmacotherapeutic research seeks to develop therapies aimed at
preventing epilepsy in patients at risk, create drugs for the reversal or prevention of
pharmacoresistance, and design drugs to inhibit the progression of epilepsy (Loscher, 2002a).
The drugs most represented in the current study include Keppra (Levetiracetam; n = 12),
Depakote (Divalproex Sodium; n =11), Lamictal (Lamotrigine; n = 11), Topamax (Topiramate, n
= 7), and Trileptal (Oxcarbazepine; n = 6). Although each drug may be associated with
distinctive side effects, generally speaking the side effects of AEDs include drowsiness,
dizziness, ataxia, nausea, vomiting, and headache. In rare cases serious side effects such as
liver failure may occur. AEDs have the potential to produce cognitive or behavioral impairment
in any patient, but many, especially among the newer AEDs, appear to be well tolerated, though
more research is needed (Bourgeois, 2004). An exception is Topamax, which will be discussed
below. Additionally, toxic AED drug levels and polytherapy are more likely to be associated with
cognitive and behavioral impairment (Bourgeois, 2004)
Keppra has been shown to be effective for primary generalized epilepsy, and partial,
generalized tonic-clonic, and myoclonic seizures, and was approved for use in 1999. The
method of action is still unclear, but may occur through the inhibition of calcium channels and/or
activation of GABA and glycine receptors. Some patients experience affective side effects
including emotional lability, depression, agitation. Unlike the other well-represented drugs in this
study, Depakote was approved in 1978 and is not a new-generation AED, although it has
recently been reformulated into extended release tablets. It has been approved for complex
partial, simple partial, and absence seizures and is believed to act through the activation of
GABA receptors. Lamictal was approved for use in 1994 and is effective in controlling many
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seizure types including absence, atonic, myoclonic, partial, and tonic-clonic. Its therapeutic
effect stems from its ability to prolong the inactivation of voltage sensitive sodium channels.
Topamax has been shown to be a very efficacious AED for many seizure types and has multiple
mechanisms of action including the inactivation of voltage-dependent sodium channels,
activation of GABA receptors, and the blockage of the activation of the non-NMDA subtype of
the glutamate inhibitors. Introduced in 1996, Topamax has been shown to be associated with a
higher risk of cognitive side effects, including an overall “cognitive dulling,” compared to other
AEDs and an associated decreased level of drug tolerance (Reith et al., 2003). More
specifically, it has been shown to be associated with cognitive impairment and word finding
difficulties, which appear to be associated with rapid titration, higher doses, and polytherapy
(Aldenkamp et al., 2000; Bourgeois, 2004; Ormrod & McClellan, 2001). Trileptal was introduced
in 2000 and is effective in controlling partial seizures. Its mechanism of action is believed to be
through the inhibition of sodium channels.
On a single AED, 60 to 88% of children are seizure-free at 12 months (Glauser et al.,
2006). Approximately 70% of children with idiopathic or cryptogenic epilepsy who are treated
with AEDs will become seizure free and as many as two thirds of these children will remain in
remission after discontinuing AED treatment (Berg & Shinnar, 1994). The level of seizure control
achieved during the first year of therapy has been shown to be a better predictor of prognosis
than clinical features at initial presentation, with the exception of developmental delay (TangWei et al., 2005). In addition to affecting cognitive outcome, AEDs also may have a detrimental
effect on behavioral outcome. One study reported that one third of parents felt that AEDs
caused a negative change in their child’s behavior or affected their child’s alertness or ability to
concentrate on the task at hand (Prahbhjot & Pratibha, 2005). This study also showed that
duration of treatment and polytherapy negatively impacted the child’s and family’s daily
activities. More research on the impact of AEDs on children’s day to day functioning is needed.

9
Effects of Epilepsy on Neuropsychololgical Functioning
Research on the effects of epilepsy on neuropsychological functioning in children is
growing, and is particularly detailed with respect to intellectual functioning, academic
achievement, and learning and memory. Results generally show a risk of deficits in at least a
subset of this population. There remains, however, a lack of research on how epilepsy and
these potential cognitive impairments may affect day to day, or adaptive, functioning in children.
Studies examining neuropsychological functioning in children with epilepsy are confounded by
the potential effects of AED therapy. No studies could be found that examined
neuropsychological functioning in drug naïve children, rather studies on this group have been
limited to examining the nature and frequency of untreated seizures to better clarify how, or if,
pharmacologic treatment might alter the course of the disease (Kwam & Sandler, 2004; van
Donselaar et al., 1997).
Cognitive Effects
Neurocognitive function has been asserted to be the most important measure of
neuronal integrity in children with epilepsy (Sankar & Rho, 2007). There is a dearth of studies
reporting results of comprehensive neuropsychological assessments of children with epilepsy.
One of the few studies to do this was conducted by Williams and colleagues (1998a). The
authors found that most cognitive skills were within the average to low average range and
commensurate with Full Scale IQ (FSIQ; which was in the low average range overall). However,
composite measures of both verbal attention (Number/Letter Memory from the Wide Range
Assessment of Memory and Learning (WRAML) and Digit Span, Arithmetic, and Information
from the Wechsler Tests of Intelligence) and visual attention (Finger Windows from the WRAML
and Coding from the Wechsler Tests of Intelligence) were significantly below expectations
based on FSIQ (Williams et al., 1998a).
The site of seizure focus may result in specific neurocognitive deficits. Specifically,
partial seizures are proposed to either disrupt hemisphere-specific functions, which would result
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in a relative weakness in the skills typically mediated by that hemisphere or to prompt brain
reorganization, which would likely result in the preservation of verbal reasoning at the expense
of nonverbal reasoning (Blackburn et al., 2007). Research has not clearly supported either of
these hypotheses; however, there does appear to be some consistency in impairments
according to the site of seizure focus. For example, temporal lobe focus is, in general,
associated with memory impairments, behavior problems, and academic underachievement
(Lassonde et al., 2000). A significant discrepancy between Verbal IQ (VIQ) and Performance IQ
(PIQ), defined as ≥ 15 points, is often considered a sign of lateralized brain dysfunction
(Blackburn et al., 2007). In children with epilepsy, significant VIQ-PIQ discrepancies were able
to accurately localize seizure focus in 79% of children with typical language organization (left
hemisphere) and 57% of those with atypical language organization (Blackburn et al., 2007).
Furthermore, within the typical language organization group, 85% of children with a significant
discrepancy, but only 63% of children without a significant discrepancy, achieved seizure control
following surgical intervention. This suggests that a large discrepancy in VIQ-PIQ is not
sufficient to lateralize seizure focus, but that such a discrepancy may help to identify those
children who will most benefit from surgical intervention.
Within the pediatric temporal lobe epilepsy population, particular attention has been paid
to assessing verbal and visual learning and memory, as these skills appear to be most
adversely affected in the adult temporal lobe epilepsy population. Indeed, as children progress
in school, they increasingly rely on language based skills, making measures of auditory
attention, verbal learning, and verbal memory important to assess. Verbal learning and memory
impairments are especially prominent in pediatric clinical populations (Delis et al., 1994), further
underscoring the need to study these skills in children with epilepsy. Verbal skills, along with
attention, have been shown to significantly predict academic achievement in children with
epilepsy (Seidenberg et al., 1987). Deficits in attention, assessed by performance on the
Wechsler Intelligence Scale for Children-Revised Digit Span and Coding subtests, have been
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shown to adversely affect the retention of verbal information in children with epilepsy (Henkin et
al., 2005) suggesting that attention is an important prerequisite for successful verbal memory.
Additionally, parent report of attention problems on the Child Behavior Checklist has been
shown to significantly predict self- and parent-ratings of everyday memory abilities in children
with epilepsy (Kadis et al., 2004).
Seizure and treatment variables have been shown to affect many aspects of
neuropsychological functioning. Variables such as earlier age at onset, higher lifetime total
seizures, presence of multiple seizure types, and the use of multiple AEDs have been shown to
correlate with academic achievement in this population (Bailet & Turk, 2000). However, Bailet &
Turk (2000) did not find significant relationships between these variables and neurocognitive
outcomes. Other research has shown that IQ scores as well as reaction times show a trend
towards being lower in children with generalized epilepsy and with higher seizure frequency
(Tromp et al., 2003). Based on a review of previous research, Lah (2004) contended that
intractable seizures that start early in life and require aggressive pharmacotherapeutic
intervention have a cumulative, negative impact on cognitive development. In children with
complex partial seizures, seizure frequency, number of AEDs, number of seizures lasting more
than 5 minutes/febrile seizures, and ethnicity were significant predictors of intellectual
functioning (Caplan et al., 2004). Furthermore, expressive language skills, assessed using the
Spoken Language Quotient of the Test of Language Development, have been shown to be
correlated with seizure frequency, number of AEDs, and ethnicity (Caplan et al., 2004).
Similar effects have been found in adults with temporal lobe epilepsy. In one study,
adverse cognitive outcomes were noted over a four year interval in approximately one quarter of
participants, with lower baseline intellectual functioning, longer duration of epilepsy, and older
chronological age predictive of poorer outcome (Hermann et al., 2006). This suggests that
chronic seizures and the continued use of AEDs are associated with decline in
neuropsychological functioning over time in a subset of adult patients. Memory, psychomotor
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speed, and some aspects of executive functioning appear to be the domains most vulnerable to
decline (Hermann et al., 2006).
Psychosocial and Behavioral Functioning
Children with epilepsy have been shown to be at increased risk for poor psychosocial
functioning (Prahbhjot & Pratibha, 2005). Behavior problems may adversely impact academic
performance as well as peer relationships, both of which are important for optimal outcomes
both in childhood and later in life. One study found that boys with a left temporal lobe focus were
more likely to be isolated, anxious, and hyperactive than boys or girls with a right temporal lobe
focus (Stores, 1978). Another study showed that children with a right temporal lobe focus
evidenced a trend towards greater risk of aggression and maladjustment (Elger et al., 1997).
Significant elevations have been found on the Attention Problems subscale of the Child
Behavior Checklist in children with epilepsy, with one study finding mean scores on this
subscale to be as high as two standard deviations above the normative mean (Williams et al.,
1998a). Such impaired attention has been hypothesized to have a generalized, and negative,
impact on learning (Sturniolo & Galletti, 1994) which would be especially detrimental in schoolage children.
Other studies have found general elevations of parent-report of internalizing problems,
but these scores have not been shown to be significantly associated with seizure, demographic,
or perinatal factors nor were they associated with expressive language abilities, assessed by
the Spoken Language Quotient of the Test of Language Development (Caplan et al., 2004).
Researchers have postulated that difficulties with school and social interaction in children with
epilepsy may be more related to subtle cognitive deficits and behavior problems than to
variables directly associated with a diagnosis of epilepsy (e.g., age at seizure onset; Caplan et
al., 2005) further underscoring the need to establish how these factors may also affect adaptive
functioning. Children with epilepsy have been found to be more socially isolated and withdrawn
than children without epilepsy (Cushner-Weinstein et al., 2007). Internalizing and externalizing
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behavior problems have been noted, and may be associated with reduced functioning across
other domains. Behavior problems also may be associated with reduced social competence
(Austin et al., 1994). Children with externalizing behavior problems may disrupt the activities of
peers and adults, be more likely to be unresponsive to adult direction, and have more
problematic relationships with peers. Furthermore, externalizing problems are more likely to be
stable than internalizing problems, and children with externalizing problems tend to have a
poorer prognosis (Robins, 1979 in Reynolds & Kamphaus, 2004). Internalizing behaviors may
be harder for informants to accurately assess, but are also associated with poorer peer
relationships (Kamphaus et al., 2003 in Reynolds & Kamphaus, 2004). In addition to the
potential association between behavior problems and reduced social competence, lack of
opportunity may also be associated with poorer social functioning (Adams et al., 2002).
Reduced opportunities for social interaction in children with epilepsy may result from missing
school as well as reduced inclusion in peer activities possibly as a result of stigmatization
(Adams et al., 2002).
Adaptive Functioning in Children with Epilepsy
Although the adverse effects of epilepsy and its treatments have been assessed on
many different aspects of functioning, their impact on adaptive functioning has not been widely
researched. Assessment of neuropsychological functioning, while of undoubted importance,
may not fully capture the impact of epilepsy and its treatments on functioning in the everyday
world (Smith et al., 2006). Measures of adaptive functioning seek to do this by assessing the
ability of people to take care of themselves and interact with and assist others at an age
appropriate level. Impairments in adaptive skills can significantly impact daily life as these skills
are necessary to live, work, and play in the community (Sparrow et al., 1984). It has been
asserted that adaptive skills should be routinely addressed in children (as well as adults) who
have impairments that interfere with daily functioning (Harrison & Boney, 2002). As people with
epilepsy and their families well know, seizures themselves as well as the fear of subsequent
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seizures can significantly interfere with daily functioning. More specifically, children with
epilepsy, particularly those with medically intractable epilepsy, are likely to require increased
supervision from adults which may interfere with the development of independence and with
social functioning. Furthermore, the social stigma associated with epilepsy (Adams et al., 2002)
may limit social opportunities and thereby hamper social development. Research is needed to
establish how epilepsy surgery and/or AED treatment may impact the development of skills
necessary for age-appropriate adaptive functioning either positively, for example, by reducing
seizure frequency or negatively, for example, through adverse side effects such as fatigue.
Adaptive functioning is an important outcome variable that requires the integration of
cognitive, emotional, and behavioral abilities into coherent behavior that is able to meet the
demands of different environments and situations. A more precise investigation of the specific
variables associated with both well and poorly developed adaptive functioning abilities is
needed within the pediatric epilepsy population. Previous research has shown that children with
intractable seizures, with a known brain insult or condition, or with an epileptic encephalopathy
(e.g. Lennox-Gastaut syndrome) may be at particular risk of failing to acquire independent living
skills at an age-appropriate rate (Berg et al., 2004). These children were shown to have below
average adaptive functioning, with significant declines relative to norms over time. In children
with epilepsy who have none of these risk factors, some researchers have found no deficits in
adaptive functioning over time (Berg et al., 2004), while others continue to find evidence of
adaptive impairments (Chapieski et al., 2005).
In a study of children all treated with monotherapy (Chapieski et al., 2005), adaptive
functioning as assessed by the Vineland Adaptive Behavior Scales (VABS; 1984) within the first
six months of diagnosis showed mean Communication domains scores to be within the low end
of the average range (M = 90.55, SD = 15.35), and mean Daily Living Skills and Socialization
scores to be in the low average range (M = 87.11, SD = 13.89 and M = 85.04, SD = 14.89
respectively) with 37%, 36%, and 39% of the sample of 56 children performing below one
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standard deviation from the mean on each of the three domains. One year later, 42 participants
and their mothers returned. Communication domain scores were comparable, with relative
declines in the Daily Living Skills (M = 84.62, SD = 16.10) and Socialization domains (M =
80.04, SD = 15.23). Thirty six percent of children were below one standard deviation from the
mean on the Communication domain, while 48% and 57% were impaired on the Daily Living
Skills and Socialization domains respectively suggestive of notable declines in the latter two
domains. Of note, all children were on a single antiepileptic medication and 66% did not
experience a single seizure in the intervening year suggesting not only that adaptive
impairments exist in children whose seizures are well-controlled by a single medication, but also
that a failure to make age-appropriate gains in adaptive functioning may be apparent even in
children with well-controlled seizures. Another study found performance to be most impaired on
the Daily Living Skills domain in very young children diagnosed with epilepsy (Berg et al., 2004),
with performance declining from the low average range at diagnosis to the mildly impaired range
one year later. In a sample of 15 children with temporal lobe epilepsy, mean adaptive
performance was in the low average (Daily Living Skills) to borderline range (Communication
and Socialization; Culhane-Shelburne et al., 2002). This study also found that measures of
executive functioning (Stroop Color-Word Interference and Tower of London Number of Rules
Broken) and impulsivity (Impulsivity on the Test of Variables of Attention) were significantly
predictive of adaptive functioning in a sample of children with either frontal or temporal lobe
epilepsy (Culhane-Shelburne et al., 2002). In general, research suggests that daily living and
socialization skills may be more vulnerable to decline in children with epilepsy, and that
impairments in adaptive functioning may occur even in children whose seizures are wellcontrolled on a single AED.
Adaptive functioning capabilities influence quality of life. Intractable seizures have been
shown to negatively impact quality of life in children (Sheth et al., 2000), and the use of
polytherapy has been showed to be associated with reduced psychosocial and physical
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functioning in children with epilepsy (Miller et al., 2003). Only two studies were found that
examined adaptive functioning in children following surgery for epilepsy. In one study, patients
underwent vertical parasagittal hemispherotomies (disconnection of the damaged hemisphere),
and a longer pre-surgical duration of seizures was associated with lower post-surgical adaptive
functioning (Delalande et al., 2007). Mean adaptive functioning was assessed using the VABS
and was found to be in the profoundly impaired range across domains for the post-surgical
sample of 58. In the other study, children underwent hemispherectomies (removal of the
hemisphere or removal of part of the hemisphere and disconnection of the remaining part) and a
longer duration of epilepsy also was found to be predictive of poorer adaptive functioning
(Basheer et al., 2007). Mean adaptive functioning scores for this sample of 24 using the Scales
of Independent Behavior-Revised (SIB-R; 1996) were poor, with mean Broad Independence
scores in the severely impaired range. At the domain level, motor scores were in the severely
impaired range, personal living, community living and support scores in the mildly impaired
range, and social/communication scores in the borderline range (Basheer et al., 2007).
Age at Seizure Onset
Childhood epilepsy is marked by abnormal electrical activity in the brain, and this may
adversely impact neural development. Research has not yet conclusively demonstrated the
extent to which age at seizure onset may affect neuropsychological functioning and it is
important to note that this variable is confounded with younger age at the start of AED therapy
and may, in some studies, be further confounded by longer epilepsy duration. A number of
research studies have shown that earlier age of seizure onset is associated with poorer
cognitive functioning (Bulteau et al., 2000; Freitag & Tuxhorn, 2005; Shoenfeld et al., 1999).
Less frequently, studies have failed to demonstrate a significant relationship between age at
onset and cognitive functioning (Bailet & Turk, 2000). In adults, childhood-onset temporal lobe
epilepsy appears to be associated with adverse neurodevelopmental impact on
neuropsychological functioning and brain structure, with reduced total white-matter volume
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compared to both healthy controls and adult-onset temporal lobe epilepsy patients (Hermann et
al., 2002). In this study, childhood-onset participants (seizures beginning before 14 years of
age) performed more poorly than control participants across all measures of neuropsychological
functioning and significantly worse than adult-onset participants (seizures beginning after 14
years of age) on seven out of 12 measures (FSIQ, PIQ, naming, spatial orientation, verbal
memory, visual memory, and problem solving) with a trend towards poorer performance on
three other measures (VIQ, fluency, face perception). Childhood and adult-onset participants
performed similarly in the area of speeded psychomotor processing, as measured by
performance on the Trail Making Tests A and B. The late-onset group, however, differed from
the controls on two out of 12 tests, performing more poorly on visual memory and speeded
processing. Childhood-onset participants showed significant reductions in total cerebral tissue
volume which was especially pronounced in white-matter tissue volume and was associated
with poorer neuropsychological outcome. Furthermore, these reductions in brain tissue volume
were not limited to the temporal lobe, and were instead found to be generalized. The results of
this study by Hermann and colleagues (2002) suggest that childhood-onset temporal lobe
epilepsy is associated with a generalized neurodevelopmental impact on brain structure and
function that is not apparent in participants with a late onset of temporal lobe epilepsy.
Other studies also have shown age at seizure onset to be an important predictor of
outcome. Children with complex partial seizures have been shown to have a broad profile of
cognitive impairment, with age at seizure onset emerging as a strong predictor of cognitive
functioning (Schoenfeld et al., 1999). The children in this study also were shown to have
reduced social and academic competence and to display more internalizing behavior problems
relative to sibling controls with seizure frequency in the last year and age at seizure onset
significant predictors of these variables (Schoenfeld et al., 1999). However, in children
diagnosed with epilepsy before the age of two, etiology as well as normal mental development
may be the biggest predictors of seizure control (Rantala & Ingalsuom 1999).
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Research by Blackburn and colleagues (2007) suggests that there may be a gradual
change from a focal deficit to more generalized impairment when seizures persist over time.
Furthermore, Lah (2004) asserts that longer epilepsy duration is associated with greater severity
of cognitive deficits, positing that continued seizures may cause progressive cognitive decline.
Blackburn and colleagues (2007) found that in children with left-hemisphere language,
significant discrepancies between VIQ and PIQ were related to shorter seizure duration and
longer seizure duration was marked by more generalized intellectual impairment (Blackburn et
al., 2007). These findings indicate that even if children benefit from the presumed greater
plasticity of the immature brain (Gleissner et al., 2005), there appear to be limits to the extent of
functional reorganization and younger age at seizure onset (and, consequently, younger age at
AED therapy commencement) may place children at greater risk of adverse
neurodevelopmental outcome with regard to brain volume white matter integrity and
neuropsychological functioning.
Time Elapsed since Epilepsy Diagnosis
Recently, more attention has been devoted to examining the degree to which
neuropsychological abnormalities are present at epilepsy onset or become evident over time.
The most effective way to determine whether epilepsy is a progressive disease is through the
use of prospective studies that assess children prior to the onset of their seizures, however,
such prospective studies are difficult, and, therefore, infrequent. A study of 72 children with
seizure disorders and their seizure-free siblings suggests that epilepsy may not be a
progressive disease (Bourgeois et al., 1983). Children were tested within two weeks of their first
documented seizure and then tested annually for four years along with their siblings. Mean IQ
of the children with epilepsy was comparable to that of their seizure-free siblings. Although
group differences were not apparent, individual changes suggested that a small subset (n = 8)
evidenced a steady decline in IQ that was associated with younger age at seizure onset, greater
likelihood of AED levels in the toxic range, and increased seizure frequency.
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Other researchers have studied children with new-onset epilepsy to better examine
trajectories (e.g., Hermann et al., 2006; Parrish et al., 2007). Children diagnosed with epilepsy
in the preceding 10 months were shown to have mean IQ scores in the average range, which
were nevertheless significantly lower relative to controls (Parrish et al., 2007). The children in
this sample were reported to have significantly greater executive functioning impairments both
according to parent report (Behavior Rating Inventory of Executive Function) and the DelisKaplan Executive Function System (D-KEFS) relative to control participants, suggesting that
executive functioning may be a vulnerable domain in children newly diagnosed with epilepsy.
Hermann and colleagues (2006) have shown that children with recent-onset epilepsy
(diagnosed within the last 12 months) exhibited a pattern of mild, but diffuse, cognitive
impairment irrespective of type of epilepsy relative to controls. Significantly poorer performance
was noted across measures of intelligence (WASI), naming (Expressive Vocabulary Test),
errors of omission (Connors’ Continuous Performance Test-II), response inhibition (D-KEFS
Color-Word Interference), and speeded psychomotor processing (WISC-III Digit Symbol). No
significant differences were observed on measures of immediate and delayed verbal and visual
memory (Children’s Memory Scale Word Lists and Dot Location) or other aspects of receptive
and expressive language (Peabody Picture Vocabulary Test-III, Boston Naming Test, and DKEFS Verbal Fluency). Furthermore, in a subset of participants, academic underachievement
appeared to pre-date the first recognized seizure. In this subset, there were volumetric
reductions in the grey matter of the left occipital and parietal lobes relative to children with
epilepsy without academic problems and relative to controls. This suggests that there might be
an antecedent neurobiological abnormality in this group and that academic functioning might be
particularly vulnerable to decline in at least some children with epilepsy. As prospective
research has shown that a history of learning problems is a significant predictor of poor longterm psychosocial outcome (Camfield et al., 1993), this finding has potentially significant
implications and warrants further exploration. Magnetic Resonance morphometric analyses
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suggest that volumetric abnormalities are not yet apparent in children newly diagnosed with
epilepsy (within the preceding 12 months), however, there are indications of an altered
structure-function relationship (Hermann et al., 2006). More specifically, control participants
showed a strong association between cognitive development and increasing cerebral tissue
volume (especially in white matter volume), whereas this relationship was absent in children
with epilepsy. There were no significant differences between the two groups with respect to
white matter volume, however, white matter integrity was not assessed. Although there is not
yet a definitive answer to the question of whether epilepsy is a progressive disorder, at the very
least there appears to be a subset of children with epilepsy whose cognitive functioning does
decline over time.
Surgical Intervention for Epilepsy
Children whose seizures are not adequately controlled by medication may undergo
surgical resection to improve seizure control, with as many as 70% seizure free following
surgery (van Empelen et al., 2005). Surgical intervention is typically considered once three
appropriate medications at therapeutic doses have failed to provide seizure control (Malphrus &
Wilfong, 2007). Candidacy for surgery is determined by a number of factors including whether a
focal onset of epileptogenic activity can be determined, surgical accessibility of the seizure
focus, proximity to areas necessary for critical skills such as speech, and the integrity of the
contralateral hemisphere (Chelune, 1995). The goal of surgery is to stop or at least significantly
reduce the frequency of intractable seizures, thereby improving quality of life. Surgical resection
is most common with a seizure focus in the temporal lobe, and is known as a temporal
lobectomy.
Many studies have focused primarily on seizure control when defining successful postsurgical outcomes (Kim et al., 2000). As the primary goal of surgical intervention is to reduce
seizure frequency, it is important to ensure that seizure control improves for the majority of
patients. This is, however, only one component of successful outcome and focusing primarily on
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it may not address the full picture of post-surgical outcome. An underlying reason for this may
be the assumption that successful seizure control will result in improvements in
neuropsychological, behavioral, and social functioning. However whether this is indeed the case
has not been fully examined (Smith et al., 2004). More recently, clinicians have begun to assess
the effects of surgical intervention on intellectual, memory, and language abilities, however, its
influence on adaptive functioning is not well researched. The key questions when evaluating
surgical outcome are whether and how surgery has altered the course of development across
domains (cognitive, adaptive, behavioral functioning and the like) from what it would have been
had the child continued to have intractable seizures (Smith et al., 2004).
Children who undergo surgical resection typically have a presurgical neuropsychological
assessment in order to quantify cognitive, behavioral, and emotional functioning at baseline.
This assessment can provide information about a child’s deficits and strengths, as well as assist
with patient selection by predicting who is at risk for significant cognitive impairments from
surgery, and aid in language lateralization (Lassonde et al., 2000). Wada testing is also typically
used as part of the presurgical work-up. In this procedure, sodium amobarbital is injected into
the internal carotid artery to temporarily incapacitate one hemisphere of the brain and determine
lateralization of memory and language abilities (Westerveld et al., 1994). Patients typically
undergo both left and right hemisphere injections. Injection ipsilateral to the seizure focus can
be used to “model” the effect of surgery and assesses the capacity for the contralateral
hemisphere to support memory and language function should the patient and family choose to
undergo surgery. Injection contralateral to the seizure focus assesses the functional adequacy
of the diseased hemisphere.
Cognitive Functioning
With respect to post-surgical intellectual functioning, many studies have shown that IQ
does not change significantly in children who have undergone temporal lobectomies (e.g.,
Williams et al., 1998b), however, some studies suggest that IQ may actually increase following
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surgery with Gilliam and colleagues (1997) reporting that 29% of their sample had a 10 point or
greater increase in VIQ or PIQ following surgery. Some of the inconsistencies across studies
with respect to post-surgical intellectual functioning might be due to different study
methodologies. For example, Westerveld and colleagues (2000) found no significant changes in
IQ across their whole sample, but when they divided the sample according to side of temporal
lobectomy they found that children who underwent a left temporal lobectomy had no significant
changes on VIQ, but improved significantly on PIQ. Children who underwent a right temporal
lobectomy did not evidence significant changes in VIQ or PIQ. Furthermore, when Westerveld
and colleagues (2000) examined individual changes, they found that 10% of their sample
experienced a significant decline and 9% experienced a significant improvement in verbal
functioning. With respect to PIQ, 16% of the sample improved significantly, and only 2% showed
significant declines.
Westerveld and colleagues (2000) examined the predictors of significant gains in
intellectual functioning following surgery. They found that younger age at surgery predicted
significant gains in verbal functioning, while higher pre-surgical VIQ was associated with a
decline in verbal functioning post-surgery. There was a trend towards males making more gains
in VIQ than females post-surgery. The authors also found evidence suggesting that structural
lesions may be a risk factor for declines in VIQ, possibly because children with such lesions
may have larger resections or get follow-up treatment (radiation, chemotherapy) which may
adversely impact cognitive functioning. Significant post-surgical increases in PIQ were best
predicted by higher pre-surgical VIQ and longer duration of follow-up (Westerveld et al., 2000).
Overall, it appears that the risk of significant decline in intellectual functioning is low, and that
there is a general trend towards improvement in intellectual functioning following surgery.
Although no significant mean changes in intellectual functioning were reported, the
above studies may be misleading as they do not account for the possible presence of practice
effects, test-retest reliability issues, and regression to the mean. Studies assessing post-
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operative change frequently do not have a comparison group nor do the researchers statistically
correct for these potentially confounding factors. All of the aforementioned studies do
acknowledge these limitations (Gilliam et al., 1997; Westerveld et al., 2000; Williams et al.,
1998b). It has been argued that looking only at absolute change, as these studies do, may be
misleading and result in high numbers of false positives or false negatives (Chelune et al.,
1996).
Although empirical methods to assess meaningful change in neuropsychological
measures, such as calculating reliable change index scores and change norms through the use
of regression have been reported, they have not been widely utilized (Chelune et al., 1996).
Westerveld and colleagues (2000) make a compelling proposal about why they do not believe
any changes in cognitive functioning in their study represent practice effects. They argue that
research has demonstrated stability in IQ over long periods of time in participants with seizures,
suggesting that practice effects cannot be assumed in this population. They also put forward
that children with intractable seizures are commonly reported to demonstrate decline rather than
improvement in cognitive functioning and that those children undergoing surgical intervention
are likely at the greatest risk for cognitive decline without intervention. Finally, they re-tested
children at an average follow-up interval of 14 months, and point out that children must
demonstrate better performance over time in order to maintain the same IQ, and that children
who fail to progress at the expected developmental rate may actually show a decline in IQ.
These arguments are thought provoking, however, they still do not appear to address
the issue of whether the reported presence or lack of change over time represents a real effect
or an artifact of re-administering the same measure. More research is needed to determine if
findings in this population are truly confounded by practice effects, test-retest reliability issues,
and regression to the mean. If children with epilepsy do not show the expected practice effects
researchers should examine why and consider the potential implications particularly for
academic functioning where practice-based learning is widely used. The possible influence of
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practice effects, test-retest reliability issues, and regression to the mean, which might mask
decline or simulate improvement in certain cognitive skills, should be kept in mind while reading
the subsequent paragraphs on post-surgical functioning. A number of the subsequent research
studies, however, have matched participants undergoing left temporal lobectomies with those
undergoing right temporal lobectomies, which, while not as ideal as a non-surgical comparison
group, does help to highlight results which may be less likely to be due to these potential
confounds.
With respect to the adult temporal lobectomy literature, deficits in verbal learning and
memory have consistently been found following left temporal lobectomy, while visual learning
and memory deficits are associated with right temporal lobectomy (e.g., Hermann et al., 1992).
Although this material-specific learning and memory deficit is considered by many to be a key
feature of temporal lobe epilepsy in adults (Lah, 2004), there are some who challenge a strict
adherence to this material-specific model contending that both right and left adult temporal
lobectomy patients are at risk of deficits in verbal memory (Baxendale & Thompson, 2005). The
picture is even less consistent in children who have undergone a temporal lobectomy. Many
aspects of neuropsychological functioning including academic skills, executive functioning, and
fine motor speed have not been shown to change significantly following surgery (Williams et al.,
1998b).
Some studies have found hemisphere specific cognitive impairments which are a
hallmark of the adult literature, with children with left temporal lobe epilepsy at greater risk of
poorer verbal memory performance, and children with right temporal lobe epilepsy at greater
risk of disrupted visual memory abilities (Adams et al., 1990; Szabo et al., 1998), but other
studies have not shown seizure focus differences (Camfield et al., 1984; Lendt et al., 1999).
Gleissner and colleagues (2002) found evidence for similar lateralization effects to adults at
short-term follow-up in children, but these effects appear to be transient as they were not
present one year following surgery. In another study Gleissner and colleagues (2005)
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demonstrated that there appears to be greater plasticity and compensational capacity in
childhood. In this study they matched children with adults also undergoing temporal lobectomy.
At 3 months post-surgery both children and adults who had undergone left temporal lobectomy
displayed a significant decline in verbal memory, but only the children recovered to their preoperative level at 1 year post-surgery. With respect to those undergoing right temporal
lobectomy, the children’s visual memory showed a transient decline at 3 months post-surgery
followed by improvement at 1 year post-surgery. Adult right temporal lobectomy patients
experienced a decline in visual memory that persisted over time. These findings suggest that
some of the inconsistencies in past studies regarding lateralization effects in children following
surgery might be the result of different periods of follow-up. Adams and colleagues (1990)
assessed functioning at 6 months post-surgery and Szabo and colleagues (1998) at 6-9 months
following surgery with both finding lateralization effects. Thus, it seems that children may be at
increased risk of a relative decline in performance within the first year following surgery, but that
these deficits on average appear to resolve one year post-surgery (Gleissner et al., 2005). This
is consistent with research which has shown that developmental gains may accrue over a
longer period of time following surgery and may not necessarily be apparent in the early months
following surgery (Freitag & Tuxhorn, 2005).
Adaptive Functioning
No studies could be identified that examined changes in adaptive functioning in children
following surgical intervention, however, adults who have undergone temporal lobectomies have
been shown to make significant improvements in psychosocial functioning as well as
independent living skills, and perform significantly better than pharmacologically managed
controls (Jones et al., 2002). Nevertheless, in this study, a quarter to a third of the surgical
group continued to experience significant psychosocial difficulties. Being seizure-free following
surgery was not a necessary prerequisite for improvements in psychosocial outcome, though
the seizure-free group did self-report significantly higher quality of life. Adults who underwent a
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temporal lobectomy were significantly more likely to live independently (85%) than adults whose
seizures were pharmacologically managed (48%) suggesting substantial relative differences in
adaptive abilities in adults treated with surgery (Jones et al., 2002). Although children with
epilepsy appear to be at risk of reduced adaptive functioning, little research has been published
assessing these deficits, their correlates, and means by which to ameliorate suboptimal
adaptive functioning. Furthermore, as surgical intervention becomes increasingly more common
to treat pharmacologically intractable pediatric epilepsy, a greater understanding of how surgery
may affect adaptive functioning is warranted.
Time Dependent Effects of Epilepsy Surgery
Gleissner and colleagues (2002) sought to better understand the time-dependent deficits
that may occur following surgery. In this study, children identified for right or left temporal
lobectomies did not differ significantly with respect to verbal memory prior to surgery, and
performance was not significantly related to duration of epilepsy, attention, or the number of
AEDs. Three months following surgery, however, the left temporal resection group showed
declines in verbal learning and delayed memory, performing significantly more poorly than the
right temporal resection group. At one year post-surgery, the left temporal resection group’s
verbal memory skills recovered such that they were no longer performing significantly more
poorly than the right temporal resection group. Interestingly, at 3 months post-surgery, both
groups evidenced a decline in verbal recognition, with recovery at 1 year post-surgery. The
degree of recovery in verbal recognition scores was only significant, however, in the right
temporal lobectomy group. Longer duration of epilepsy was a predictor for poorer post-operative
verbal learning, and similarly to the findings of Szabo and colleagues (1998) higher preoperative
verbal learning and memory performance were significant predictors of post-operative loss. This
finding might represent an actual loss of verbal learning and memory skills, regression to the
mean, reduced functional integrity of the side contralateral to surgery, or greater functional
adequacy of the resected tissue (Chelune et al., 1995).
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Surgery may cause new deficits or exacerbate those already present, but it may also
result in the restoration of cognitive processes and behavioral functioning. For example,
significant improvements following temporal resection (left or right) have been noted in language
performance and attention (Gleissner et al., 2005; Lendt et al., 1999), psychomotor speed
(Gleissner et al., 2002), and problem solving abilities (Hermann & Wyler, 1988). Duchowny and
colleagues (1992) contacted families following their children’s surgery and found reported
increases in the children’s self-esteem and self-confidence, as well as improved mood. Childreport of post-surgical gains in competence and self-worth also were noted by van Empelen and
colleagues (2005). Parents also have reported significant improvements in their child’s social
relationships and activities, an increase in independence, increased mood, more energy,
decreased fatigue, and reductions in internalizing behavior problems following surgery (Elliot et
al., 2000; Smith et al., 2004; van Empelen at al., 2005; Williams et al., 1998b). Children who are
younger at time of surgery may show a greater improvement in behavior problems following
surgery (Smith et al., 2004). Many of cited improvements in neuropsychological functioning
appear to be linked to the degree of seizure control (Smith et al., 2004).
Early surgical intervention is becoming increasingly popular for children with epilepsy,
because it might not only lead to improved seizure control, but also help to normalize brain
development and because more immature brains may be more plastic allowing for greater postsurgical recovery (Holmes 1996; Rossi, 1995; Wyllie, 1998). Early surgical intervention also
could halt the detrimental effects of seizures on the brain, help facilitate academic achievement,
and aid in the development of social and adaptive skills (Lah, 2004). Indeed, continual seizures
are thought to slow the rate of cognitive and psychological development (Hirsch et al., 2000).
Nevertheless, the optimal time for surgical intervention in childhood remains controversial, with
surgery currently offered most often as a last-resort treatment (Sheth et al., 2000). More
longitudinal studies are needed to help shed light on this issue.
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Children with below average intellectual functioning are less likely to attain post-surgical
seizure control than children with average intellectual ability (Chelune et al., 1998; Lee et al.,
2004 in Blackburn et al., 2007). This is consistent with research on adults with epilepsy. It has
been postulated that below average intellectual functioning in this population is a marker of
diffuse neuronal damage, which cannot be addressed through a focal resection (Blackburn et
al., 2007). Nevertheless, the effect sizes are small when using baseline IQ scores to predict
pediatric seizure outcome suggesting that IQ scores alone may be of little utility in identifying
surgical candidacy. Due to the linear relationship between IQ and later seizure freedom,
however, IQ may be of more utility in estimating the chance of becoming seizure free postsurgery (Chelune et al., 1998).
Surgical intervention results in improved seizure control for many children, with
approximately 70% seizure-free in the first year following surgery (Gilliam et al., 1997; Gleissner
et al., 2002). Positive post-surgical seizure and AED outcomes appear to decline over time, with
a higher percentage of children being seizure free and off of AEDs within the first five years of
surgery, as compared to more than five years following surgery (Tellez-Zenteno et al., 2007).
Children have, however, been shown to have better post-surgery seizure outcomes than adults
with epilepsy, with 27% of children off of AEDs and seizure-free at 5 year follow-up as
compared to 19% of adults (Tellez-Zenteno et al., 2007). This may reflect surgery during
childhood having an increased probability of curing epilepsy or differences in the extent of
surgical resection in children as compared to adults. Temporal lobectomies are the most
prevalent type of seizure surgery in children and appear to have the highest rate of success with
respect to seizure control (Kim et al., 2000). Other neuroanatomical variables also may
influence surgical outcome. For example, children with symptomatic epilepsy as evidenced by
the presence of discrete lesions on MRI show improved seizure control compared to children
with no lesion or non-specific MRI findings (Kim et al., 2000).
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Surgical intervention in children does not seem to be associated with a substantial risk of
greater neuropsychological impairments, and some children may even make cognitive gains
following temporal lobectomy. Research conducted thus far suggests that the risk of cognitive
impairment following temporal lobectomy is small, with learning and memory abilities appearing
to be the most vulnerable, and any deleterious effects in these domains may be transient. The
minimal risk of adverse outcome that many studies report is important to note because children
who undergo temporal lobectomies are those in whom seizures are most difficult to control and
who are at the greatest risk of delays in cognitive and psychological development without
surgical intervention (Gleissner et al., 2005; Westerveld et al., 2000). Nevertheless, more
research is needed to examine the effects of surgery on other outcomes, such as adaptive
functioning, and to provide more information on the variables that correlate with optimal and
suboptimal seizure control and cognitive functioning. More studies that control for the effects of
practice, test-retest reliability issues, and regression to the mean also are needed.
Infrequent Use of Comparison Groups
In addition to a poor understanding of adaptive functioning in this population, past
research also has been limited by the infrequent use of comparison groups. Comparison groups
are important in neuropsychological research because they help to clarify how people with
neurological impairments are functioning differently from their peers without neurological
impairments. Comparison groups also are beneficial in studies where the same measures are
administered multiple times, as they can help control for practice effects. The use of comparison
groups in pediatric neuropsychological research is particularly important to ensure that any
findings in a neurological sample are not due to developmental trends, but rather reflect
meaningful deviations from the norm with respect to brain development and function. The use of
comparison groups in studies of epilepsy, particularly those assessing post-surgical outcome
has been infrequent, with Lendt and colleagues (1997) emphasizing the need for controlled
comparisons in order to accurately characterize the benefits of surgery. An informal search of
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PubMed in Spring 2009 using the search terms “pediatric, epilepsy, comparison group” and
“pediatric, epilepsy, control group” revealed 59 studies that have used comparison groups when
conducting research in this population. This is in stark contrast to the 3,094 studies that were
listed using the search terms “pediatric, epilepsy.” Adding the word “cognitive” to the above
search terms revealed 8 studies with comparison groups and 206 studies without comparison
groups.
Comparison groups are of particular importance when trying to assess change over
time. For example, Hermann and colleagues (2006) assessed the neuropsychological
functioning of adults with chronic epilepsy at one time point and again four years later. They
also tested healthy controls at these same intervals. When examining only the epilepsy patients,
the course of epilepsy might erroneously have been concluded to be benign as mean
performance on only one out of 16 measures changed significantly. However, the inclusion of a
healthy control group painted a dramatically different picture as 57% of the control group
showed significant improvements on the tests, while only 6% of the epilepsy group improved
significantly. This suggests that test-retest trajectories are very different for the two groups and
that the majority of participants with chronic epilepsy failed to make the expected gains from
learning associated with practice effects. When assessing children after a temporal lobectomy,
a non-surgical comparison group with epilepsy is of particular importance in order to better
understand how surgery may alter the relationship being examined. This is because without a
comparison group, it is impossible to know whether a relationship has been affected by surgical
intervention, ongoing development, the course of the seizure disorder, or some combination of
the above (Smith et al., 2004).
The use of a typically developing comparison group can be beneficial as it allows for
commentary on how the course of development may deviate from the norm in clinical samples.
One study examined the prevalence of parent-report of behavior problems in children with
seizures, children with heart conditions, and typically developing children (McDermott et al.,
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1995). They found that behavior problems were 3 times more likely in children with heart
conditions and 4.7 times more likely in children with epilepsy compared to control participants.
Furthermore, children with epilepsy were noted to be at greater risk of hyperactive and
dependent behaviors (McDermott et al., 1995). This suggests that epilepsy itself or factors
associated with epilepsy such as compromised developmental status or higher rates of learning
disabilities, attention deficit disorders, and behavioral disorders (Adams et al., 2002) are
associated with a notably greater increase in the number of parent-reported behavior problems
compared not only to children with a different chronic medical condition, but also to children who
are developing typically.
The Current Study
Understanding the influence of epilepsy and its treatments on adaptive functioning will
help researchers quantify the effects of these variables on neurodevelopment and to fine-tune
neuropsychological interventions. In order to better understand how these variables affect
adaptive functioning, children with epilepsy and a typically developing, seizure free
(comparison) group were recruited for this study. This study was conducted at two time points
with Time 1 representing when children underwent a neuropsychological evaluation and Time 2
when parents completed follow-up questionnaires on their child’s functioning. This study
examined the relationship between individual and cumulative measures of seizure severity and
adaptive functioning. Additionally, the relationship between neuropsychological functioning at
Time 1 and adaptive functioning at Time 2 was studied in order to establish the best
neuropsychological predictors of later adaptive functioning. As intact language based skills,
such as auditory attention, verbal learning, and verbal memory, are especially critical for schoolage children and because impairments in these areas may be especially prominent in pediatric
clinical populations (Delis et al., 1994) and associated with academic underachievement
(Seidenberg et al., 1987), measures of these constructs were the focus.
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The relationship between behavior problems, executive functioning, and adaptive
functioning also was assessed. Children with epilepsy are known to be at risk of behavior
problems (Caplan et al., 04; Elger et al., 1997; Stores 1978), which are associated with reduced
psychosocial functioning (Adams et al., 2002; Austin et al., 1994). Executive functioning, which
refers to cognitive abilities that are necessary for goal-directed behavior, has been shown to be
a particularly vulnerable domain in children with epilepsy (Hermann et al., 2006; Parrish et al.,
2007), and is associated with adaptive outcome (Culhane-Shelburne et al., 2002).
Neuropsychological functioning was examined as a mediator of the relationship between
seizure severity/group membership and adaptive functioning. This model was proposed to
better understand the causal relationship between variables, and to establish whether seizure
and treatment variables directly affect adaptive functioning or indirectly affect it through altering
cognitive or behavioral functioning.
With the ultimate goal of improving the lives of children with epilepsy, more research is
needed in order to increase our understanding of the variables associated with positive adaptive
outcome, suggest means by which to assist children in achieving an optimal level of ageappropriate independence, and help in the identification of children who are at risk of suboptimal
adaptive functioning so that preventative interventions may be applied. The first specific aim of
this study sought to establish the extent to which a measure of cumulative seizure severity as
well as individual seizure and treatment variables were able to predict adaptive functioning. The
second specific aim was designed to address whether seizure and treatment variables either
directly affected adaptive functioning, or indirectly affected it through their effects on
neuropsychological functioning. These aims were designed to highlight the key variables
associated with positive adaptive outcome and quantify the effects of seizure and treatment
variables on adaptive functioning.
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Specific Aims
Aim 1: Establish how epilepsy and treatment variables were related to adaptive
functioning.
Hypothesis 1: More severe epilepsy history was hypothesized to be negatively related to
adaptive functioning.
Hypothesis 2: Longer amount of time elapsed since first seizure, younger age at seizure
onset, active seizures, multiple medications, and multiple seizure types were predicted to be
negatively associated with independent living skills.
Hypothesis 3: Focal epilepsy surgery was hypothesized to be positively related to
adaptive functioning.
Aim 2: Establish the strongest neuropsychological predictors of adaptive functioning
and whether neuropsychological functioning mediated the relationship between seizure
and treatment variables and adaptive functioning.
Hypothesis 1: Attention (California Verbal Learning Test-Children’s Edition (CVLT-C,
1994) Trial 1), verbal learning (CVLT-C Learning Slope), and verbal memory (CVLT-C Long
Delay Free Recall) at Time 1 were proposed to be positively related to adaptive functioning
(Adaptive Behavior Assessment System-II (ABAS-II, 2003) Conceptual, Social, and Practical
domains) at Time 2. Executive dysfunction (Behavior Rating Inventory of Executive Function
(BRIEF, 2000) Behavioral Regulation Index and Metacognitive Index) was hypothesized to be
negatively associated with adaptive functioning at Time 2.
Hypothesis 2: Behavior problems (Behavior Assessment System for Children-Second
Edition (BASC-2, 2004) Internalizing and Externalizing Problems) at Time 1 were predicted to
be negatively associated with independent living skills at Time 2.
Hypothesis 3: Based on the results of hypotheses 1 and 2, verbal learning (CVLT-C
Learning Slope), executive functioning (BRIEF General Executive Composite (GEC)), and
behavior problems (BASC-2 Behavior Problems Composite) at Time 1 were predicted to
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mediate the relationship between Seizure History Scale (SHS) scores at Time 1 and adaptive
functioning at Time 2 (see Figure 1a). Furthermore, this relationship was hypothesized to persist
when neuropsychological functioning and SHS scores at Time 2 (both when SHS scores at
Time 1 were controlled for and when they were not) were used (see Figure 1b).
As it is more traditional to divide children with epilepsy into groups according to their
treatment status, an additional meditational model was tested using group membership as a
predictor of adaptive functioning. A dummy coded variable represented group membership
(Time 1: 0 = typically developing, 1 = monotherapy, and 2 = polytherapy; Time 2: 0 = typically
developing, 1 = monotherapy, 2 = polytherapy, and 3 = surgical).
Hypothesis 4: Verbal learning (CVLT-C Learning Slope), executive functioning (BRIEF
GEC), and behavior problems (BASC-2 Behavior Problems Composite) at Time 1 were
predicted to mediate the relationship between Group at Time 1 and adaptive functioning at Time
2 (see Figure 2a). Furthermore, this relationship was hypothesized to persist when examining
neuropsychological functioning and Group at Time 2 (both when Group at Time 1 was controlled
for and when it was not; see Figure 2b).
With the ultimate goal of improving the lives of children with epilepsy, this study sought
to increase our understanding of how the developing brain is affected by this chronic illness and
its treatment and to suggest means by which to fine tune interventions to improve adaptive skills
in order to assist children in achieving an optimal level of age-appropriate independence.
Chapter 2
METHOD
Participants
Children with epilepsy and their families were recruited from a larger group of children
who were referred to Children’s Healthcare of Atlanta (CHOA) for a neuropsychological
evaluation. Children on monotherapy and polytherapy for seizure control were eligible to
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Time 1
BRIEF General Executive Composite
Or
BASC-2 Behavior Problems
Composite
C

A

B

Time 1
Seizure History Scale
C

C

Time 2
ABAS-II Adaptive
Functioning

Figure 1a. Mediational model examining executive functioning or behavior problems at Time 1
as a mediator of the relationship between the Seizure History Scale at Time 1 and adaptive
functioning at Time 2.
Note. Verbal learning was dropped as a mediator due to a non-significant correlation with the Seizure History Scale.
When executive functioning was examined as a mediator, behavior problems were controlled for and vice versa.
Abbreviations: BRIEF, Behavior Rating Inventory of Executive Functioning; BASC-2, Behavior Assessment System
for Children 2nd Edition; ABAS-II, Adaptive Behavior Assessment System 2nd Edition.
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Time 2
BRIEF General Executive Composite
Or
BASC-2 Behavior Problems
Composite
C

A

B

Time 2
Seizure History Scale
C

C

Time 2
ABAS-II Adaptive
Functioning

Figure 1b. Mediational model examining executive functioning or behavior problems at Time 2
as a mediator of the relationship between the Seizure History Scale at Time 2 and adaptive
functioning at Time 2.
Note. Verbal learning was dropped as a mediator due to a non-significant correlation with the Seizure History Scale.
When executive functioning was examined as a mediator, behavior problems were controlled for and vice versa. This
model was tested both when performance on the Seizure History Scale at Time 1 was controlled for and when it was
not to examine the effects of changes in seizure history between Time 1 and Time 2. Abbreviations: BRIEF, Behavior
Rating Inventory of Executive Functioning; BASC-2, Behavior Assessment System for Children 2nd Edition; ABAS-II,
Adaptive Behavior Assessment System 2nd Edition.
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Time 1
BRIEF General Executive Composite
Or
BASC-2 Behavior Problems
Composite
C

A

B

Time 1
Group
C

C

Time 2
ABAS-II Adaptive
Functioning

Figure 2a. Mediational model examining executive functioning or behavior problems at Time 1
as a mediator of the relationship between Group at Time 1 and adaptive functioning at Time 2.
Note. Verbal learning was dropped as a mediator due to a non-significant correlation with Group. Group represents
whether the child belongs to the Typically Developing, Monotherapy, or Polytherapy group. When executive
functioning was examined as a mediator, behavior problems were controlled for and vice versa. Abbreviations:
BRIEF, Behavior Rating Inventory of Executive Functioning; BASC-2, Behavior Assessment System for Children 2nd
Edition; ABAS-II, Adaptive Behavior Assessment System 2nd Edition.
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Time 2
BRIEF General Executive Composite
Or
BASC-2 Behavior Problems
Composite
C

A

B

Time 2
Group
C

C

Time 2
ABAS-II Adaptive
Functioning

Figure 2b. Mediational model examining executive functioning or behavior problems at Time 2
as a mediator of the relationship between Group at Time 2 and adaptive functioning at Time 2.
Note. Verbal learning was dropped as a mediator due to a non-significant correlation with Group. Group represents
whether the child belongs to the Typically Developing, Monotherapy, Polytherapy, or Surgery group. When executive
functioning was examined as a mediator, behavior problems were controlled for and vice versa. This model was
tested both when Group at Time 1 was controlled for and when it was not to examine the effect of changes in group
membership between Time 1 and Time 2. Abbreviations: BRIEF, Behavior Rating Inventory of Executive Functioning;
BASC-2, Behavior Assessment System for Children 2nd Edition; ABAS-II, Adaptive Behavior Assessment System 2nd
Edition.
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participate. Children who underwent a focal resection for the purpose of seizure control also
were eligible to participate. Presurgical neuropsychological assessments were used for this
group in order to determine the extent to which their post-surgical functioning could be predicted
by how participants were functioning prior to surgical intervention. Children who had more than
one surgical resection were eligible for participation in the study provided that a
neuropsychological evaluation was conducted prior to the initial resection. Typically developing
children and their families who participated in another study at CHOA, were recruited for the
comparison group. Inclusion in this group was contingent on not having received a diagnosis of
epilepsy.
Regardless of group, inclusion in this study was contingent upon children being between
the ages of 6 and 16 at the time of the initial neuropsychological evaluation (Time 1). At least
one year, but fewer than five years, must have elapsed between the neuropsychological
screening and the completion of parent-report questionnaires (Time 2). Only families who spoke
English as a first language were eligible to participate. Children who were diagnosed with a
brain tumor were eligible for participation only if they had not been treated with radiation or
chemotherapy. Participants diagnosed with a specific learning disability (n = 5; 1 spelling, 2
math, 2 reading), attention deficit/hyperactivity disorder (n = 12) or with a history of traumatic
brain injury (n = 1) were eligible to participate given their high rates of comorbidity with epilepsy,
and their diagnoses were noted to help characterize the sample. Children who were diagnosed
with an additional distinct neurological disorder such as Neurofibromatosis or Autism or who had
epilepsy associated with a neurodegenerative disorder (e.g., progressive myoclonic epilepsy)
were excluded, because being diagnosed with an additional neurological disorder with known
neurocognitive impairments would have undermined our ability to draw conclusions about the
specific effects of epilepsy and seizure treatments on adaptive functioning. Children with Chiari
Type 1 Malformations (n = 3) were eligible to participate because this structural defect is not
reliably associated with neurocognitive impairments, but rather is typically associated with
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physical symptoms such as dizziness, headache, neck pain, and muscle weakness (NINDS,
2007). Furthermore, when the analyses were run without these participants, the results did not
change appreciably.
One hundred and forty-one families were eligible to participate in this study. Twenty-six
families were unable to be located (typically developing = 6, monotherapy = 17 (two of whom
later underwent surgery) and, polytherapy = 3). Three families declined participation (all
monotherapy), and thirty-four families (typically developing = 3, monotherapy = 23 and,
polytherapy = 8) did not answer phone calls about participation. A total of 78 families consented
to participate. Sixteen families of these families did not return packets (typically developing = 4,
monotherapy = 8 (two of whom later underwent surgery) and, polytherapy = 4). Means,
frequencies, and significant differences between children who participated in the study and
those who did not are presented in Table 1. Children from the monotherapy group who
participated in the study were more likely to have active seizures at Time 1, than children who
did not participate (Χ2 (1, n = 75) = 7.07, p = .01). Children treated with monotherapy who did
not participate had significantly more executive problems as measured by the Behavioral
Regulation Index of the BRIEF (t(72) = -2.18, p = .03) than children who did participate, but
mean scores for both groups were within normal limits. The age of seizure onset was found to
be significantly lower for polytherapy participants compared to non-participants (t(36) = -2.30, p
= .03). Typically developing children who participated in the study had more externalizing (t(27)
= 4.43, p < .001) and executive problems (General Executive Composite t(27) = 2.41, p = .02;
Behavioral Regulation Index t(27) = 2.57, p = .02) compared to non-participants, but still scored
within normal limits.
Sixty two eligible families completed participation in this study (46 with children with
epilepsy, 16 typically developing). Within the epilepsy group, at Time 1, 23 children were
prescribed a single AED and 23 children were prescribed multiple AEDs. At Time 2, 17 children
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Table 1. Means (standard deviations) and frequencies for children who participated in the study and those who did not at Time 1.

Monotherapy

Polytherapy

Typically Developing

Participants
n = 23

Non-Participants
n = 51

Participants
n = 23

NonParticipants
n = 15

Participants
n = 16

Non-Participants
n = 13

Age at
Neuropsychological
Assessment (years)

12.01 (3.05)

10.91 (2.82)

11.22 (3.27)

11.84 (2.67)

11.75 (2.99)

11.40 (3.58)

Age at Seizure
Onset (years)

7.07 (4.98)

6.15 (3.93)

4.87 (3.00) c

7.33 (3.54) c

-

-

21:2 a

31:20a

22:1

15:0

-

-

1.91 (.90)

1.98 (.71)

1.91 (.95)

1.80 (.56)

1.25 (.45)

1.23 (.44)

Female:Male

7:16

24:27

8:15

4:11

7:9

6:7

Caucasian:African
American

21:2

39:12

18:5

13:2

9:7

8:5

Right:Left
Handedness

21:2

42:9

15:8

13:2

15:1

13:2

Number with IEP at
School

9

25

14

7

0

0

Number in
Accelerated
Program at School

1

2

1

0

0

0

Active: Controlled
Seizures
Socioeconomic
Status
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Monotherapy

Polytherapy

Typically Developing

Participants
n = 23

NonParticipants
n = 51

Participants
n = 23

NonParticipants
n = 15

Participants
n = 16

NonParticipants
n = 13

CVLT-C Trial 1

93.48 (15.05)

94.71 (14.95)

86.30 (11.00)

95.00 (17.85)

103.75 (14.23)

95.96 (16.66)

CVLT-C Learning Sl.

94.78 (16.84)

95.29 (17.81)

99.35 (22.94)

86.50 (12.74)

99.53 (13.82)

107.50 (13.35)

CVLT-C LDFR

87.61 (24.83)

92.35 (17.26)

87.28 (20.53)

86.00 (21.93)

104.22 (11.93)

106.35 (9.61)

BASC-2
Internalizing

105.35 (17.13)

110.49 (19.36)

108.74 (19.64)

119.50 (21.54)

96.53 (7.66)

91.23 (6.53)

BASC-2
Externalizing

102.74 (18.14)

110.64 (19.19)

107.70 (18.61)

111.25 (19.14)

102.81 (7.35) d

91.23 (6.53) d

BRIEF GEC

112.78 (26.21)

123.33 (15.70)

120.22 (19.22)

127.10 (21.22)

100.94 (11.95) e

92.04 (6.46) e

BRIEF BRI

106.75 (21.88)b

117.53 (18.29) b

115.68 (20.08)

123.50 (22.82)

101.41(11.97) f

91.12 (8.95) f

BRIEF MI

115.75 (26.51)

124.12 (15.78)

121.00 (18.73)

126.10 (18.37)

100.47 (13.47)

92.38 (7.10)

Wechsler Full Scale
IQ

94.00 (16.38)

89.48 (15.76)

87.74 (18.74)

81.07 (14.68)

114.50 (11.65)

108.15 (16.76)

Note. Non-participants included children who could not be located (n = 27), children whose parents did not return calls about participation (n = 36), children whose
parents declined to participate (n = 3), and children whose packets were not completed (n =16). Socioeconomic status was scored on a 5 point scale
(Hollingshead, 1957) with 1 representing the highest socioeconomic status and 5 the lowest. Significant differences between groups are indicated by a superscript
letter. Higher scores on the BASC-2 and BRIEF indicate worse functioning. Abbreviations: IEP, Individualized Education Plan; CVLT-C, California Verbal Learning
Test-Children’s Version; Learning Sl., Learning Slope; BASC-2, Behavior Assessment System for Children 2nd Edition; BRIEF, Behavior Rating Inventory of
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Executive Functioning; GEC, Global Executive Composite; BRI, Behavioral Regulation Index; MI, Metacognition Index. Significant differences between groups are
indicated by a superscript letter.
a

Χ2 (1, n = 75) = 7.07, p = .01

b

t(72) = -2.18, p = .03

c

t(36) = -2.30, p = .03

d

t(27) = 4.43, p < .001

e

t(27) = 2.41, p = .02

f

t(27) = 2.57, p = .02
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were prescribed a single AED, 15 children were prescribed multiple AEDs (one was also on the
ketogenic diet), and 14 children had undergone a temporal lobectomy (nine right, five left; M =
2.42 years ago, SD = 1.56, range = 1.00-5.00 years). Although children who underwent focal
surgical resections in other areas of the brain were eligible to participate, only three other
children underwent focal resections and were within the age-range of this study. All three were
excluded for other reasons, namely for co-morbid neurological conditions. Demographic data
are presented in Table 2. Socioeconomic status (SES) was assessed by the Hollingshead TwoFactor Index of Social Position (Hollingshead, 1957) which uses parental occupation and
educational level to estimate SES. This is a five point scale with one representing the highest
socioeconomic status and five the lowest. Mean SES was higher than average across all four
groups.
T-tests and Fisher Exact tests were used to test for significant differences between
groups. The surgery group was found to be significantly older than the monotherapy (t(29) = 2.32; p = .03), polytherapy (t(27) = -2.52; p = .02), and typically developing (t(28) = -2.27; p =
.03) groups at the time parents completed the questionnaires, and may reflect the current view
that surgery is a “last-resort” treatment. The amount of time elapsed between
neuropsychological assessment and the completion of questionnaires (Times 1 and 2) was
significantly longer for children in the monotherapy group compared to the polytherapy( t(30) =
3.13, p = .004) and typically developing (t(31) = -4.07, p = .001) groups and for children in
surgery group compared to the polytherapy (t(27) = -3.01, p = .09) and typically developing
(t(28) = -3.35, p = .005) groups. The surgery group had a significantly later onset of epilepsy
than the polytherapy group (t(27) = -2.55; p = .02). SES was significantly higher for the typically
developing group compared to the monotherapy (t(31) = -2.61; p = .01) and surgery (t(28) = 3.19; p = .01) groups. Compared to the typically developing group, the surgery group was found
to be comprised of significantly more Caucasian children (Fisher Exact (1, n =30) = 5.12; p =
.04). Children in the polytherapy group were significantly more likely to be left handed than
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Table 2. Demographic information according to group at Time 2.

Monotherapy
(n = 17)

Polytherapy
(n = 15)

Surgery
(n = 14)

Typically
Developing
(n = 16)

Age at Neuropsychological
Assessment (years)

10.80 (3.16)

11.42 (2.98)

12.81 (3.19)

11.73 (2.95)

Age at Questionnaires
(years)

12.90 (3.30)a

12.82 (2.84)b

15.53
(2.95)a,b,c

13.05 (3.03)c

Time between
Neuropsychological
Assessment and
Questionnaires (years)

2.08 (.78)de

1.37 (.43)df

2.69 (1.58)fg

1.25 (.31)eg

Age at Seizure Onset (years)

5.17 (3.36)

4.46 (2.68)h

8.55 (5.41)h

-

Time between Seizure Onset
and Questionnaires (years)

7.69 (4.12)

8.34 (3.84)

6.94 (5.31)

-

7:10

13:2

6:8

-

1.94 (.97)i

1.60 (.63)

2.21 (1.05)j

1.25 (.45)i,j

Female:Male

8:9

2:13

5:9

7:9

Caucasian:African
American

15:2

11:4

13:1k

9:7k

Right:Left Handedness

14:3

9:6l

13:1

15:1l

Number with IEP at School

9m

9n

5o

0mno

Number in Accelerated
Program at School

0

2

1

0

Active:Controlled Seizures
Socioeconomic Status

Note. Socioeconomic status was scored on a 5 point scale (Hollingshead, 1957) with 1 representing the highest
socioeconomic status and 5 the lowest. Abbreviations: IEP, Individualized Education Plan. Significant differences
between groups are indicated by a superscript letter.
a

t(29) = -2.32, p = .03

b

t(27) = -2.52, p = .02

c

t(28) = -2.27, p = .03

d

t(30) = 3.13, p = .004

e

t(31) = -4.07, p = .001

f

t(27) = -3.01, p = .09
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g

t(28) = -3.35, p = .005

h

t(27) = -2.55, p = .02

i

t(31) = -2.61, p = .01

j

t(28) = -3.19, p = .01

k

Fisher Exact (1, n = 30) = 5.12, p = .04

l

Fisher Exact (1, n = 31) = 5.04, p = .04

m

Fisher Exact (1, n = 33) = 11.65, p = .001

n

Fisher Exact (1, n = 31) = 13.53, p < .001

o

Fisher Exact (1, n = 30) = 6.86, p = .01
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children in the typically developing group (Fisher Exact (1, n =31) = 5.04; p = .04). Finally,
children across the monotherapy (Fisher Exact (1, n =33) = 11.65; p = .001), polytherapy
(Fisher Exact (1, n =31) = 13.53; p < .001), and surgery (Fisher Exact (1, n =30) = 6.86; p = .01)
groups were significantly more likely to have an Individualized Education plan (IEP) in place
than children in the typically developing group.
Information regarding medications and seizure types is presented in Table 3. The
number of participants currently prescribed specific AEDs (or combination of AEDs where
applicable) is listed according to group membership. This is followed by the number of past
AEDs a child has been prescribed, again presented according to the number of participants per
group. Then the number of participants per group experiencing different seizure types is listed.
Additionally, two children in the monotherapy group and one child in the surgery group had
experienced infantile spasms. On average, children within the monotherapy group experienced
2.18 (SD = 1.13) different types of seizures, children within the polytherapy group 2.13 (SD
=1.13), and children within the surgery group 1.86 (SD = 1.03). There were no significant
differences in the mean number of seizure types experienced per group (tmonotherapy vs. polytherapy(30)
= .11, p = .92; tmonotherapy vs. surgery(29) = .82, p = .42; tmonotherapy vs. polytherapy(27) = .69, p = .50). The
total number of current AEDs children were taking was significantly greater for the polytherapy
group compared to the monotherapy group (t(30) = 16.00, p < .001) and the surgery group
(t(27) = 4.38, p = .001). At time 1, 43 children had experienced at least one seizure in the last
year (active), compared to three who had not experienced a single seizure in the last year
(controlled; 2 monotherapy, 1 polytherapy). At Time 2, 26 children had active seizures (7
monotherapy, 13 polytherapy, 6 surgery) and 20 children had controlled seizures (10
monotherapy, 2 polytherapy, 8 surgery). Additionally, at Time 2, children in the polytherapy
group were significantly more likely to have had one or more seizures in the last year compared
to the monotherapy group (Fisher Exact (1, n = 32) = 7.04, p = .01) and the surgery group
(Fisher Exact (1, n = 29) = 6.15, p = .02).
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Table 3. Names of current Antiepileptic Drugs (AEDs), number of past AEDs, and seizure types
at Time 2 according to group membership.
Number of Participants
Monotherapy
(n = 17)

Polytherapy
(n = 15)

Surgery
(n = 14)

None

-

-

4

Keppra

5

-

4

Trileptal

3

-

1

Depakote

2

-

1

Lamictal

3

-

1

Zonegran

1

-

-

Topamax

3

-

-

Keppra & Zarontin

-

1

-

Keppra & Carbatrol

-

1

-

Keppra & Depakote

-

-

1

Depakote & Zonegran

-

2

-

Depakote & Dilantin

-

1

-

Depakote & Carbatrol

-

1

-

Depakote & Topamax

-

1

-

Depakote & Trileptal

-

-

1

Depakote & Lamictal

-

2

-

Lamictal & Topamax

-

2

-

Lamictal & Tranxene

-

2

-

Current AEDs
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Number of Participants
Monotherapy
(n = 17)
-

Polytherapy
(n = 15)
1

Surgery
(n = 14)
-

Keppra, Topamax, & Lamictal

-

-

1

Trileptal, Phenobarbital, & Mysoline

-

1

-

None

3

1

4

One

8

1

4

Two

4

1

2

Three

1

5

1

Four

-

1

0

Five or More

1

6

3

Simple Partial

4

3

2

Complex Partial

9

7

10

Secondarily Generalized

1

1

-

Absence

11

7

6

Atypical Absence

1

1

1

Tonic-Clonic

11

7

7

Clonic

-

1

-

Myoclonic

1

1

-

-

1

-

Zonegran & Klonopin

Number of Past AEDs

Seizure Types
Partial

Generalized

Other
Eyelid Myoclonia

50
Gelastic

-

1

-

Febrile

2

-

1

Status Epilepticus

1

1

-

Note. Abbreviations: AEDs; Antiepileptic Drugs

51
A summary of neuropsychological functioning at both Times 1 and 2 is presented in
Table 4. Although mean scores were typically within the average to low average range,
asubstantial percentage of children in each of the epilepsy groups was functioning below the
25th percentile (or above the 25th percentile on the BASC-2 and BRIEF where higher scores
indicate more problems). Significant between group differences in neuropsychological
functioning based on t-tests are presented in Table 5. The epilepsy groups did not differ
significantly from each other on any measure of neuropsychological functioning at either time
point. Between group differences were noted between the epilepsy groups and typically
developing group, with the children in the typically developing group performing significantly
better than children with epilepsy on many measures. Although children with epilepsy were
found to have significantly poorer adaptive functioning compared to typically developing
children, when IQ was controlled for an Analysis of Covariance showed that there were no
longer significant differences between groups on adaptive functioning (F(3, 57) = .30, p = .83).
At Time 2, within the monotherapy group, seven children had experienced at least one
seizure in the last year (active seizures) and 10 had not experienced any seizures in the last
year (controlled seizures). In the polytherapy group, 13 children had active seizures, and two
had controlled seizures. Within the surgery group, six had active seizures, and eight had
controlled seizures. Scores on the Seizure History Scale (SHS; see Appendix A) were compiled
to compare the severity of cumulative seizure history across participants. The range of possible
scores was 0 to 22, with higher numbers indicating more severe seizure history. Overall, the
mean score at Time 1 was 9.41 (SD = 3.33), and 8.48 (SD = 4.58) at Time 2. Mean scores on
the SHS at Time 1 were 7.96 (SD = 3.17) for the monotherapy group and 10.87 (SD = 2.87) for
the polytherapy group. At Time 2, mean scores on the SHS were 5.94 (SD = 3.60) for the
monotherapy group, 12.00 (SD = 4.00) for the polytherapy group, and 7.79 (SD = 4.04) for the
surgery group.
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Table 4. Mean neuropsychological performance in standard scores across groups and percentage below normal.

Monotherapy
n = 23
Time 1

Mean (SD)

Polytherapy
n = 23

%age
Below
Normal

Mean (SD)

Surgery
n=0

%age
Below
Normal

Mean (SD)

Typically Developing
n = 16
%age
Below
Normal

Mean (SD)

%age
Below
Normal

CVLT-C Trial
1

93.48 (15.05)

39

86.30 (11.00)

57

-

-

103.75 (14.23)

25

CVLT-C
Learning Sl.

87.61 (24.83)

35

99.35 (22.94)

30

-

-

99.53 (13.82)

31

CVLT-C
LDFR

90.54 (20.75)

39

87.28 (20.53)

48

-

-

104.22 (11.93)

13

BASC-2
Internalizing

105.35 (17.13)

35

108.74 (19.64)

43

-

-

96.53 (7.66)

0

BASC-2
Externalizing

102.74 (18.14)

39

107.70 (18.61)

30

-

-

102.81 (7.35)

19

BRIEF GEC

112.78 (26.21)

43

120.22 (19.22)

65

-

-

100.94 (11.95)

19

BRIEF BRI

106.75 (21.88)

35

115.68 (20.08)

57

-

-

101.41(11.97)

25

BRIEF MI

115.75 (26.51)

43

121.00 (18.73)

70

-

-

100.47 (13.47)

13

Wechsler
Full Scale IQ

94.00 (16.38)

35

87.74 (18.74)

57

-

-

114.50 (11.65)

0
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Monotherapy
n = 17
Mean (SD)
%age
Below
Normal

Polytherapy
n = 15
Mean (SD)
%age
Below
Normal

Surgery
n = 14
Mean (SD)
%age
Below
Normal

BASC-2
Internalizing

107.68 (15.27)

35

108.70 (16.54)

33

108.14 (24.70)

43

97.56 (10.40)

13

BASC-2
Externalizing

102.12 (16.70)

29

107.70 (17.34)

40

108.68 (20.38)

57

98.97 (11.43)

13

BRIEF GEC

118.18 (18.86)

65

120.30 (15.05)

73

115.00 (25.54)

57

98.69 (14.48)

25

BRIEF BRI

110.59 (16.92)

59

113.70 (16.93)

67

115.86 (27.06)

43

97.75 (12.49)

13

BRIEF MI

121.10 (20.68)

65

121.60 (14.05)

80

113.61 (23.24)

57

101.03 (16.95)

38

ABAS-II
GAC

90.24 (22.43)

47

89.47 (14.62)

60

89.14 (23.76)

64

105.00 (13.64)

13

ABAS-II
Conceptual

90.94 (20.00)

47

90.40 (15.38)

60

92.79 (23.33)

50

107.06 (10.56)

6

ABAS-II

91.53 (28.34)

35

91.33 (16.18)

33

92.64 (21.03)

43

104.44 (13.58)

6

86.35 (24.33)

53

89.93 (13.71)

73

89.14 (25.73)

64

103.25 (15.50)

25

Time 2

Typically Developing
n = 16
Mean (SD)
%age
Below
Normal

Social
ABAS-II
Practical

Note. Higher scores on the BASC-2 and BRIEF indicate worse functioning. %age Below Normal was defined as the percentage of children in each group
performing at or below the 25th percentile (SS ≤ 90; CVLT-C, IQ, ABAS-II) or at or above the 25th percentile (SS ≥ 110; BASC-2, BRIEF) based on norms.
Abbreviations: &age Below Normal, Percentage Below Normal; CVLT-C, California Verbal Learning Test-Children’s Version; Learning Sl., Learning Slope; BASC-

54
2, Behavior Assessment System for Children 2nd Edition; BRIEF, Behavior Rating Inventory of Executive Functioning; GEC, Global Executive Composite; BRI,
Behavioral Regulation Index; MI, Metacognition Index; ABAS-II, Adaptive Behavior Assessment System 2nd Edition; GAC, General Adaptive Composite.
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Table 5. Significant differences between groups on neuropsychological measures at Time 1 and Time 2 according to t-tests.

Monotherapy
vs.
Polytherapy

Monotherapy vs.
Typically Developing

Polytherapy vs.
Typically Developing

CVLT-C Trial 1

-

t(37) = 2.14, p =.04

t(37) = 4.32, p <.001

CVLT-C
Learning Sl.

-

-

-

CVLT-C LDFR

-

t(37) = 2.78, p =.01

t(37) = 2.96, p =.01

BASC-2
Internalizing

-

t(37) = -2.18, p =.04

t(37) = -2.36, p =.02

BASC-2
Externalizing

-

-

-

BRIEF GEC

-

-

t(37) = -3.86, p <.001

BRIEF BRI

-

-

t(37) = -2.73, p =.10

BRIEF MI

-

t(37) = -2.32, p =.03

t(37) = -3.75, p =.001

Wechsler Full
Scale IQ

-

t(37) = 4.30, p <.001

t(37) = 5.06, p <.001

Time 1
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Monotherapy
vs.
Polytherapy

Monotherap
y vs.
Surgery

Monotherapy vs.
Typically Developing

Polytherapy
vs. Surgery

Polytherapy vs.
Typically Developing

Surgery vs. Typically
Developing

BASC-2
Internalizing

-

-

t(31) = -2.21, p =.04

-

t(29) = -2.21, p =.04

-

BASC-2
Externalizing

-

-

-

-

-

-

BRIEF GEC

-

-

-

-

-

-

t(29) = -3.31, p
=.002
t(29) = -2.47, p =.02

-

BRIEF BRI

t(31) = -3.31, p
=.002
t(31) = -2.47, p =.02

t(28) = -2.30, p =.03

BRIEF MI

-

-

t(31) = -3.02, p =.01

-

t(29) = -3.02, p =.01

-

ABAS-II GAC

-

-

t(31) = 2.30, p =.03

-

t(29) = 2.30, p =.03

t(28) = 2.20, p =.04

ABAS-II
Conceptual

-

-

t(31) = 2.92, p =.01

-

t(29) = 2.92, p =.01

-

ABAS-II Social

-

-

-

-

-

-

ABAS-II
Practical

-

-

t(31) = 2.36, p =.03

-

t(29) = 2.36, p =.03

-

Time 2

Note. Abbreviations: vs., versus; CVLT-C, California Verbal Learning Test-Children’s Version; BASC-2, Behavior Assessment System for Children 2nd
Edition; BRIEF, Behavior Rating Inventory of Executive Functioning; GEC, Global Executive Composite; BRI, Behavioral Regulation Index; MI, Metacognition
Index; ABAS-II, Adaptive Behavior Assessment System 2nd Edition; GAC, General Adaptive Composite.
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With respect to comorbidities at Time 2, within the monotherapy group, five children had
been diagnosed with ADHD, and four of these were taking stimulant medication. Of these five,
one child had also been diagnosed with Obsessive Compulsive Disorder (OCD) and another
child was noted to have a Chiari Type 1 Malformation, which was asymptomatic and had not
been treated. Within the polytherapy group, five children were diagnosed with ADHD, and two of
these were taking stimulant medication. An additional child in the polytherapy group had
undergone decompression surgery for a Chiari Type 1 Malformation. Finally, one child within the
polytherapy group had a history of traumatic brain injury preceding seizure onset. Within the
surgery group, two children were diagnosed with ADHD, and both of these were taking stimulant
medication. One child within the surgery group was noted to have a Chiari Type 1 Malformation,
which was asymptomatic and had not been treated. Additionally, one child was diagnosed with
OCD, and another child had a history of traumatic brain injury preceding seizure onset.
Seizure localization information was available on all children who had undergone videoEEG monitoring. Within the monotherapy group, three children were reported to have a bilateral
frontal focus, one a left frontal focus, one a right frontal focus, one a bilateral temporal focus,
one a left mesial temporal focus, three bilateral fronto-temporal, one right hemisphere focus,
one child with left parietal-occipital and bifrontal foci, and four were found to have generalized
seizure activity. One child in this group had not undergone any localization testing. Within the
polytherapy group, two children were reported to have a bilateral frontal focus, one a left frontal
focus, one left temporal focus, one bilateral fronto-temporal, one left hemisphere focus, one
child with left parietal and right frontal foci, one child with a right posterior temporal-occipital
focus, and five had generalized seizure activity. Two children in this group had not undergone
localization testing. Within the surgery group, nine children underwent a right temporal
lobectomy. Three of the children in the right temporal lobectomy group had been diagnosed with
a brain tumor (2 ganglioglioma, 1 Dysembryoplastic Neuroepithial tumor (DNET)). Two children
were diagnosed with right mesial temporal sclerosis, and four children were noted to have
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multifocal discharges within the temporal lobe, one of whom underwent a surgical revision 3
months after her initial surgery because of persistent seizures. Five children underwent a left
temporal lobectomy all following diagnosis of a brain tumor (3 ganglioglioma, 1 astrocytoma, 1
DNET). No child diagnosed with a brain tumor had received adjuvant therapy prior to
participating in this study.
Parents/guardians (the term parent will be used hereafter for simplicity) completed
questionnaires on their children at both Times 1 and 2. Whenever possible, the same parent
completed the questionnaires at both time points. At Time 1, 54 mothers, 7 fathers, and 1
grandmother completed the questionnaires. At time 2, 56 mothers, five fathers, and one
grandmother completed the questionnaires. Three fathers and two mothers, who completed the
questionnaires at Time 1, were unable to complete them at Time 2 due to work/time
commitments. Additionally, one father was unable to complete the questionnaires at Time 2 due
to neurological illness. In all of these cases, their spouse was able to complete the
questionnaires at Time 2.
Experimental Design
This study was approved by the Institutional Review Boards of Georgia State University
(H08028) and CHOA (07-008). Both children and parents assented/consented prior to
participating in this study. All children completed a neuropsychological screening (consisting of
Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV, 2003; n = 24) or Wechsler
Abbreviated Scale of Intelligence (WASI, 1999; n = 38) and California Verbal Learning TestChildren’s Edition (CVLT-C, 1994)) and a parent completed the Behavior Assessment System
for Children-Second Edition (BASC-2, 2004) and Behavior Rating Inventory of Executive
Function (BRIEF, 2000) at Time 1. Between one and five years later (M = 1.83, SD = 1.04), at
Time 2, a parent completed the Adaptive Behavior Assessment System-II (ABAS-II, 2003),
BASC-2, and BRIEF as well as a seizure information form. All families were recruited through
CHOA. Prior to contacting families, medical records were reviewed to determine study eligibility.
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Eligible families were then contacted by telephone, and those who consented to participate
completed the ABAS-II, BASC-2, and BRIEF. Three parents requested to complete the
questionnaires over the phone because it was easier for them, and one because they were
recovering from hand surgery. Completion of these questionnaires took approximately 45
minutes. Prior neuropsychological testing results were collected from participant’s medical
records in order to understand how these results related to children’s current level of
functioning. Previous testing results were collected for the following measures: (1) WISC-IV or
WASI, (2) CVLT-C, (3) BASC-2, and (4) BRIEF.
Typically developing children were recruited through a database maintained on children
who have previously served as comparison participants for other studies at CHOA. This
database was examined to identify children who met the inclusion criteria for this study. These
families were contacted by telephone, and, if they consented to participate, completed the
ABAS-II, BASC-2, and BRIEF. As an incentive to participate, parents were offered a summary
of their child’s strengths and weaknesses based on the results of the questionnaires.
Measures
Adaptive Functioning
The Adaptive Behavior Assessment System-II (Harrison & Oakland, 2003) was
administered at Time 2 and is designed to assess whether an individual displays the functional
skills necessary for age-appropriate daily living without the assistance of others. This measure
includes a General Adaptive Composite (GAC), which is comprised of 3 domains: Conceptual,
Social, and Practical. The Conceptual domain is comprised of the communication, functional
academics, and self-direction skill areas, and assesses skills such as taking turns during
conversations, reading menus at restaurants, and saving money to buy something special. The
Social Domain is made up of the leisure and social skill areas and assesses behavior such as
participating in an organized program for a sport or hobby, inviting others home for a fun activity,
and offering assistance to others. The Practical Domain is comprised of the community use,
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home living, health and safety, and self-care skill areas and assesses skills such as folding
clean clothes, calling for help if someone is hurt, and tying one’s shoes. The ABAS-II has
numerous applications including diagnosis and classification, identification of adaptive strengths
and weaknesses, as well as the identification of service needs and planning and monitoring of
progress.
Although the few studies examining adaptive functioning in this population primarily have
used the Vineland Adaptive Behavior Scales (VABS; Sparrow et al., 1984; Sparrow et al.,
2005), the ABAS-II was chosen for this study for a number of reasons. The first is because of
the better reliability of the ABAS-II as compared to the VABS-II. Internal consistency, test re-test
reliability and inter-rater reliability are all higher for the ABAS-II (.97-99, .90, .90 respectively)
than for the VABS-II (.93-.97, .80, .75). The second is to increase the likelihood of participation.
The ABAS-II is a parent-report questionnaire that takes less than 30 minutes to complete and
can be completed at the parent’s convenience, while the VABS-II is a survey form that takes
approximately 60 minutes to complete and must be administered by a trained researcher.
Additionally, the ABAS-II GAC has been shown to correlate significantly (r = .78) with the
Adaptive Behavior Composite of the VABS-II suggesting that there is substantial overlap in the
construct they measure. The two measures cluster adaptive skills differently, but correlations
among domains measuring similar content range from .60 to .74 for the age range of this study.
With respect to validity of the ABAS-II, factor analysis has confirmed the presence of a
unified single factor of adaptive functioning (GAC) as well as a close-fitting three-factor model.
Within a typically developing sample, the parent report version of the ABAS-II has been shown
to correlate moderately with FSIQ on the WISC-IV (r = .41). At the domain level, the Conceptual
Domain is most highly correlated with FSIQ (r = .49), followed by the Social Domain (r = .35),
and the Practical Domain (r = .28). Similar correlations are reported for the WASI. Adaptive
functioning was shown to be more highly correlated with FSIQ as assessed by the WISC-IV
when using a mixed clinical sample. The correlation between FSIQ and ABAS-II GAC was
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moderate (r = .58), with performance on the Conceptual Domain most highly correlated with
FSIQ (r = .63), followed by the Practical Domain (r = .53), and the Social Domain (r = .43).
Learning and Memory
The California Verbal Learning Test (CVLT) assesses the ability to encode information,
store it, and later retrieve it. Participants completed the CVLT-Children’s Version (CVLT-C; Delis
et al., 1994) at Time 1. Learning Slope and the Long Delay Free Recall Trial were used to
assess verbal learning and memory. List A of the CVLT-C is comprised of 15 words, with five
words from each of 3 semantic categories. The Learning Slope quantifies the mean number of
new words per trial that an examinee acquires across the five immediate recall trials of List A.
This variable has been shown to be sensitive to certain types of memory impairment, such as a
“flat learning curve” where performance on List A, Trial 1 is normal or close to normal, but few
words are learned on subsequent trials (Luria, 1981 in Delis et al., 1994). The Long Delay Free
Recall Trial is a measure of free recall after a 20 minute delay (filled with nonverbal testing).
On the CVLT-C, test-retest reliability is modest, ranging from .59 to .73 on the selected
variables. These reliability coefficients are not surprising given the nature of the measure, as readministration of the test within a short time (a median of 28 days) might allow children to build
upon their learning from the initial administration. Factor analysis indicated that the multiple
variables of the CVLT-C cluster into theoretically meaningful factors consistent with the
constructs they were designed to measure. In children with epilepsy, performance on the CVLTC has not been shown to differ significantly from typically developing children when seizures are
well-controlled (Williams et al., 2001), but children whose seizures are poorly controlled show
reduced overall learning relative to controls (Hernandez et al., 2003).
Attention
List A, Trial 1 of the CVLT-C was used as a measure of attention. It is the first immediate
recall trial of List A and is a measure of auditory attention span (Delis et al., 1994). It is a
supraspan measure because participants are presented with more stimuli than the immediate
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attention span can hold. This overload condition is believed to be especially sensitive to deficits
in attention (Lezak et al., 2004).
Executive Functioning
The Behavior Rating Inventory of Executive Function (BRIEF; Gioia et al., 2000) is a
parent questionnaire assessing executive functioning behaviors in children 5-18 years old and
was completed at Times 1 and 2. Executive functions are responsible for directing and
managing cognitive, emotional, and behavioral functions which are typically involved in problemsolving behavior. For this study, parents completed the questionnaire, and the Behavioral
Regulation (BRI) and Metacognition (MI) Indices and Global Executive Composite (GEC) were
used. The BRI is a reflection of the child’s ability to shift cognitive set and use inhibitory control
to modulate emotions and behavior. This index is comprised of the Emotional Control, Shift, and
Inhibit scales. The MI reflects a child’s ability to initiate, plan, organize, and sustain futureoriented problem solving in working memory. This index is comprised of the Initiate, Working
Memory, Plan/Organize, Monitor, and Organization of Materials scales. The BRIEF GEC
assesses a child’s ability to shift set, use inhibitory control to modulate emotions and behavior,
and ability to initiate, plan, organize, and sustain future-oriented problem solving in working
memory. Test-retest reliability is high, with coefficients in the mid to upper .80s for both indices
and the composite.
There are two validity scales: the Inconsistency Scale examines the extent to which
similar items are answered differently and the Negativity Scale examines the extent to which
items are answered in an unusually negative manner. Scores on these two scales were
examined to ensure test profiles were valid. Scores on the Inconsistency Scale were within
acceptable limits. Scores on the Negativity Scale were elevated for 8 children (number of
typically developing children = 0; monotherapy = 4; polytherapy = 2, surgery = 2; number of
children with active seizures = 4, controlled seizures = 4), and consistent with the guidelines
presented in the Users’ Manual (Gioia et al., 2000), these children’s profiles were reviewed
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more closely and examined within the broader context of their previous neuropsychological
assessment and any additional commentary from parents. In all cases, children were reported
to be experiencing substantial levels of executive dysfunction, which was most likely the
underlying reason for the elevation on this scale (Gioia et al., 2000), so their data were retained.
Good convergent and divergent validity of the BRIEF scales has been demonstrated through
correlations with scales from the Behavior Assessment System for Children-2, Child Behavior
Checklist, and Conner’s Rating Scale. Furthermore, the BRIEF has been shown to be highly
correlated with an objective measure of executive functioning, the Delis-Kaplan Executive
Function System, in children with epilepsy (Parrish et al., 2007). Factor analysis has confirmed
the two factor model supporting the presence of the BRI and MI (Gioia et al., 2000).
Behavior Problems
The Behavior Assessment System for Children-Second Edition (BASC-2; Reynolds &
Kamphaus, 2004) measures many aspects of behavior and child personality. Parents completed
the Parent Ratings Scale of the BASC-2 at Times 1 and 2. This study used the Externalizing
and Internalizing Problems composite scores. The Externalizing Problems composite is
comprised of the hyperactivity, aggression, and conduct problems scales, which are all
characterized by disruptive behavior. The Internalizing Problems composite consists of the
anxiety, depression, and somatization scales. Children with internalizing problems are likely to
excessively monitor their own actions and to be excessively compliant, so their symptoms may
be more likely to go unnoticed. At the scale level, T-scores in the 60-69 range are considered
At-Risk, and T-scores of 70 or above are considered Clinically Significant. Test-retest reliability
for the BASC-2 for the Internalizing and Externalizing Problems composites is typically in the
mid .80s to low .90s for children and adolescents. Interrater reliabilities are in the high .60s to
the high .70s. Symptoms of externalizing behaviors are usually more obvious that internalizing
behaviors, which may account for slightly higher levels of interrater agreement on the
Externalizing Behaviors composite. The validity of composite scores has been confirmed
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through factor analysis. The BRIEF GEC correlates moderately to highly with parent-report of
externalizing problems.
Validity of the report is assessed through an F index which assesses whether a parent
rates their child in a highly negative fashion. Profiles with an F Index in the Caution or Extreme
Caution range suggest that a negative response set may have skewed the results. A
Consistency Index identifies cases where differing responses are given on questions typically
answered similarly. Scores on these indices were examined, and all test profiles were found to
be valid.
Recent research has suggested that parent-report measures of internalizing behavior
problems that include a measure of physical symptoms may be erroneously elevated in
chronically ill children with the potential for real physical complaints being mislabeled as
reflecting psychosocial disturbance (Friedman et al., 2007). The Internalizing Problems
composite of the BASC-2 is comprised of the somatization, anxiety, and depression scales.
Prior to including the Internalizing Problems composite in our analyses, scores on the individual
scales were examined to determine whether they were significantly elevated relative to norms
and/or significantly more elevated than other scales on children’s profiles according to critical
values provided in the manual. Scores on this scale were not found to be significantly elevated
relative to norms or scores on other scales of the Internalizing Problems composite. Therefore,
the somatization scale was retained as part of the Internalizing Problems composite.
Intellectual Functioning
Intellectual functioning was assessed for all participants in this study at Time 1. IQ was
used for general description of cognitive functioning, but was not used as a predictor in the
models. This was because of the greater theoretical interest in examining the predictive utility of
specific constructs, rather than general measures of cognitive integrity, where it would be harder
to tease apart the key ability (or abilities) accounting for significant findings. Furthermore, IQ has
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been reported to be highly correlated with adaptive functioning, particularly in clinical samples
(Harrison & Oakland, 2003).
Participants in this study were administered either the Wechsler Intelligence Scale for
Children-IV (WISC-IV; Wechsler, 2003; n = 24) or the Wechsler Abbreviated Scales of
Intelligence (WASI; Wechsler, 1999; n = 38). The WISC-IV provides a measure of general
intellectual functioning as well as four composite scores for children: Verbal Comprehension
(VCI), Perceptual Reasoning (PRI), Working Memory (WMI), and Processing Speed (PSI). This
measure has 10 core subtests and can be administered to children from ages 6 years 0 months
to 16 years 11 months. WISC-IV scores possess adequate test-retest reliability (Wechsler,
2003). Reliability coefficients are particularly robust for the four composite scores as well as the
FSIQ. Factor analysis confirmed the existence of one core factor (FSIQ) as well as four factors
(index scores). The WISC-IV FSIQ is highly correlated with both the FSIQ-4 (r = .83) and FSIQ2 (r = .86) of the WASI. Subtest correlations range from the low to high .70s.
The WASI is a short and reliable measure that provides an estimate of an individual’s
general level of intellectual functioning. It consists of four subtests: Vocabulary, Block Design,
Similarities, and Matrix Reasoning from which a Full Scale IQ-4 (FSIQ-4), VIQ, and PIQ can be
generated. For children, test-retest reliability coefficients were .93, .94, and .96 for the VIQ, PIQ
and FSIQ-4 respectively.
Seizure Variables
In some analyses, participants were grouped according to their epilepsy status. The
groups were: monotherapy, polytherapy, surgery, and typically developing. When group
membership was examined as a predictor of adaptive functioning, group was treated as an
ordinal variable with typically developing membership coded as 0, monotherapy as 1,
polytherapy as 2, and surgery as 3. The following seizure and treatment variables were included
in the analyses: age at seizure onset, amount of time elapsed since first seizure, active
seizures, more severe epilepsy history, multiple medications, multiple seizure types, and
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whether or not focal epilepsy surgery was performed. This information was collected from
medical record review and a parent questionnaire (see Appendix B). Age at seizure onset was
measured in months. The amount of time elapsed since first seizure was calculated by
subtracting the date the Time 2 questionnaires were completed from the date of the participant’s
first known seizure and was measured in months. Active seizures was a dichotomous variable
with 0 defined as no seizures in the past 12 months (controlled) and 1 defined as one or more
seizures in the past 12 months (active; Fastenau et al., 2004).
Multiple medications was a continuous variable reflecting the number of medications a
child was taking for the purpose of seizure control at Time 2. Multiple seizure types were
entered in the model as a continuous variable that reflected the number of different seizure
types a participant had experienced since being diagnosed with epilepsy. A value of 1
represented that a participant had only experienced one type of seizure, a value of two that a
participant had experienced 2 different types of seizures and so on. Whether or not focal
epilepsy surgery was performed was a dichotomous variable with 0 representing no surgical
intervention and 1 representing that focal epilepsy surgery was conducted. All children in this
study had their resections completed by the same neurosurgeon at CHOA.
Although researchers have created seizure severity scales to assess current seizure
severity (e.g., Baker et al., 1998; Breau et al., 2008; Carpay et al., 1996), no scale could be
identified that examined the cumulative effects of seizure history since the time of diagnosis in
children. For this purpose, the Seizure History Scale (SHS; see Appendix A) was created to
compare the severity of seizure history across participants. This measure is comprised of items
that assess seizure frequency broadly, lifetime seizure types, lifetime history of status
epilepticus, current number of AEDs, AED history, and surgical intervention for seizure control.
The range of possible scores was 0 to 22, with higher numbers indicating more severe seizure
history.
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Chapter 3
RESULTS
Scores were converted to Standard Scores so that all data were on the same
quantitative scale for ease of interpretation. Prior to conducting our analyses, the assumptions
of regression were tested (Lewis-Beck, 1980). Data were visually inspected to ensure that a
linear model was applicable. There was one outlier (an outlier was defined as a Standard Score
of ≤ 40 or ≥ 160) on the BRIEF GEC (SS = 175). When the analyses were re-run without this
participant, the results did not change appreciably, so this participant was retained in the
analyses. The assumptions of homoskedasticity and that the residuals are approximately
normally distributed were met. Correlation analyses were conducted with those measures
chosen for inclusion in the models to confirm the absence of multicollinearity (see Tables 6-9).
Age at seizure onset and the amount of time elapsed between seizure onset and completion of
the parent questionnaires were found to be highly correlated (r = .72; p < .001), therefore the
latter was dropped from our model. Descriptive statistics for BASC-2, BRIEF, and CVLT-C at
Time 1 and the BASC-2, BRIEF, and ABAS at Time 2 are presented in Table 4.
For our first specific aim and the first two hypotheses of our second aim, linear
regression analyses were used. For the remaining hypotheses of specific aim 2, mediation was
tested. With a meditational model, there are a number of different pathways of interest (see
Figures 1 & 2). The total effect, or c pathway, denotes the relationship between the independent
variable (IV) and dependent variable (DV). C’, or the direct effect, refers to the effect of the IV on
the DV after controlling for the mediator. The a pathway refers to the effect of the IV on the
mediator and the b pathway to the effect of the mediator on the DV. The ab pathway, or indirect
effect, is the product of the a and b pathways (also c – c’). The significance of the ab pathway
was tested according to Preacher and Hayes (2004; 2008), which calculates the direct and
indirect effects similarly to the Baron and Kenny method, but affords greater statistical power
through its use of bootstrap estimation (Mallinckrodt et al., 2006). Bootstrapping is a
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Table 6. Correlation matrix between seizure and treatment variables at Time 2 and adaptive functioning.

ABAS-II
Conceptual

ABAS-II
Practical

ABAS-II
Social

Age at
Seizure
Onset

Active
Seizures

Number of
Current AEDs

ABAS-II Practical

.92**

-

ABAS-II Social

.66**

.71**

-

Age at Seizure
Onset

.20

.16

.14

-

Active Seizures

-.46**

-.43**

-.47**

-.12

-

Number of
Current AEDs

-.28

-.18

-.19

-.30*

.44**

-

Number of Past
AEDs

-.07

-.26

-.30

-.25

.26

.43**

-

Number of
Seizure Types

-.15

-.07

-.12

-.03

.14

-.03

.14

-

Temporal Lobe
Surgery

.05

.03

.00

.41**

-.18

-.33*

-.12

-.13

Note. Abbreviations: ABAS-II, Adaptive Behavior Assessment System 2nd Edition; AEDs, Antiepileptic Drugs.
*p(one-tailed) <.05, **p(one-tailed) <.01

Number of
Past AEDs

Number of
Seizure
Types
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Table 7. Correlation matrix for variables at Time 1.

Group

Active
Seizures

Active Seizures

.76**

-

SHS

.83**

.86**

-

CVLT-C Trial 1

-.46**

-.38

-.41*

-

.01

.00

-.01

.35*

-

CVLT-C Long Delay
Free Recall

-.29*

-.34*

-.37

.40**

-.28*

BASC-2 Internalizing

.28*

.25*

.35*

.30*

.11

-.03

-

BASC-2 Externalizing

.13*

.07

.07

-.04

-.20

-.05

.48**

-

BRIEF GEC

.35*

.28*

.31*

-.24*

-.16

-.18

.60**

.75**

CVLT-C Learning
Slope

SHS

CVLT-C
Trial 1

CVLT-C
Learning
Slope

CVLT-C
Long Delay
Free Recall

BASC-2
Internalizing

BASC-2
Externalizing

-

Note. Active seizures denotes whether or not a child has had one or more seizures in the last year. Abbreviations: SHS, Seizure History Scale; CVLT-C, California
Verbal Learning Test-Children’s Version; BASC-2, Behavior Assessment System for Children 2nd Edition; BRIEF, Behavior Rating Inventory of Executive
Functioning; GEC, Global Executive Composite.
*p(one-tailed) <.05, **p(one-tailed) <.001.
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Table 8. Correlation matrix for variables at Time 2.

Group

SHS

.07

Active
Seizures
-

SHS

.62**

.77**

-

BASC-2 Internalizing

.21*

.32*

.44**

-

BASC-2 Externalizing

.23*

.15

.22*

.44**

-

BRIEF GEC

.29*

.44**

.50**

.67**

.73**

-

ABAS-II Conceptual

-.26*

-.54**

-.47**

-.42**

-.50**

-.70**

-

ABAS-II Social

-.26*

-.43**

-.41*

-.45*

-.59**

-.60**

.80**

-

ABAS-II Practical

-.21

-.50**

-.40*

-.41**

-.44**

-.64**

.92**

.81**

Active Seizures

BASC-2
Internalizing

BASC-2
Externalizing

BRIEF
GEC

ABAS-II
Conceptual

ABAS-II
Social

Note. Group represents whether the child belongs to the Typically Developing, Monotherapy, Polytherapy, or Surgery group. Active seizures denotes whether or
not a child has had one or more seizures in the last year. Abbreviations: SHS, Seizure History Scale; CVLT-C, California Verbal Learning Test-Children’s Version;
BASC-2, Behavior Assessment System for Children 2nd Edition; BRIEF, Behavior Rating Inventory of Executive Functioning; GEC, Global Executive Composite.
*p(one-tailed) <.05, **p(one-tailed) <.001.
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Table 9. Correlation matrix between variables at Time 1 and Time 2.

Time 1

Time 2

Group

Active
Seizures

SHS

BASC-2
Internalizing

BASC-2
Externalizing

BRIEF
GEC

ABAS-II
Conceptual

ABAS-II
Social

ABAS-II
Practical

Group

.71**

.59**

.78**

.37*

.21

.41**

-.42**

-.32*

-.34*

Active Seizures

.74**

.42**

.65**

.24*

.13

.36*

-.31

-.19

-.20

SHS

.71**

.53**

86**

.39*

.17

.40*

-.34*

-.28*

-.26*

CVLT-C Trial 1

-.40**

-.40**

-.43**

-.36*

-.09

-.31

.30*

.12

.29*

CVLT-C Learning
Slope

.06

.16

.09

.02

-.14

-.03

-.13

-.03

-.08

CVLT-C Long
Delay Free Recall

-.34*

.01

-.28*

-.24

-.08

-.21

.20

.07

.19

BASC-2
Internalizing

.24*

.34*

.41**

.69**

.41**

.60**

-.43**

-.42**

-.42**

BASC-2
Externalizing

.08

.18

.19

.28*

.73**

.59**

-.46**

-.19

-.42**

BRIEF GEC

.17

.39*

.40*

.45**

.59**

.78**

-.69**

-.51**

-.65**

Note. Group at Time 1 represents whether the child belongs to the Typically Developing, Monotherapy, or Polytherapy group. Group at Time 2 represents whether
the child belongs to the Typically Developing, Monotherapy, Polytherapy, or Surgery group. Active seizures denotes whether or not a child has had one or more
seizures in the last year. Abbreviations: SHS, Seizure History Scale; CVLT-C, California Verbal Learning Test-Children’s Version; BASC-2, Behavior Assessment
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System for Children 2nd Edition; BRIEF, Behavior Rating Inventory of Executive Functioning; GEC, Global Executive Composite; ABAS-II, Adaptive Behavior
Assessment System 2nd Edition.
*p(one-tailed) <.05, **p(one-tailed) <.001.
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nonparametric approach to hypothesis testing that can be used with small samples with greater
confidence than the Baron and Kenny method. The number of bootstrap samples was set to
20,000 (Preacher & Hayes, 2008) meaning that 20,000 samples of our n of 62 were taken and
the ab pathway was calculated for each. The mean of the 20,000 ab pathways was then used to
calculate confidence intervals. When zero is not within the confidence interval, the null
hypothesis that the ab pathway is not significantly different from zero can be rejected. Bias
corrected and accelerated 95% confidence intervals were used.
Primary Analyses
Aim 1: Establish how epilepsy and treatment variables were related to adaptive
functioning.
Hypothesis 1: More severe epilepsy history was hypothesized to be negatively related to
adaptive functioning.
To examine the cumulative and interactive effects of seizure and treatment severity,
three regressions were conducted with the SHS as the independent variable and the three
domains of the ABAS-II as the dependent variables. This measure was able to explain 10%,
8%, and 8% of the variance in the Conceptual (b = -1.58, SE = .74, p (one-tailed) = .02), Social
(b = -1.63, SE = .85, p (one-tailed) = .03), and Practical (b = -1.64, SE = .83, p (one-tailed) =
.03) domains.
Hypothesis 2: Longer amount of time elapsed since first seizure, younger age at seizure
onset, active seizures, multiple medications, and multiple seizure types were predicted to be
negatively associated with independent living skills.
Hypothesis 3: Focal epilepsy surgery was hypothesized to be positively related to
adaptive functioning.
Linear regressions were conducted to examine the relationship between seizure and
treatment variables and adaptive functioning. Age at seizure onset, active seizures, multiple
medications, multiple seizure types, and whether or not focal epilepsy surgery was performed.
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were entered as independent variables. This model was run with the 3 different domains of the
ABAS-II as dependent variables: Conceptual, Social, and Practical scores. The model was able
to explain 28%, 26%, and 23% of the variance across the three domains. Active seizures
emerged as the only significant predictor of adaptive functioning across domains, with active
seizures associated with lower adaptive functioning (see Table 10 and Figure 3). The active
seizures variable was uniquely able to explain 14%, 9%, and 15% of the variance across the
three domains.
Aim 2: Establish the strongest neuropsychological predictors of adaptive functioning
and whether neuropsychological functioning mediated the relationship between seizure
and treatment variables and adaptive functioning.
Hypothesis 1: Attention (CVLT-C Trial 1), verbal learning (CVLT-C Learning Slope), and
verbal memory (CVLT-C Long Delay Free Recall) at Time 1 were proposed to be positively
related to adaptive functioning (ABAS-II Conceptual, Social, and Practical domains) at Time 2.
Executive dysfunction (BRIEF BRI and MI) was hypothesized to be negatively associated with
adaptive functioning at Time 2.
Due to the high correlation between the BRI and MI (r = .79, p < .001) of the BRIEF, the
composite score (BRIEF GEC) was used instead. Linear regression analyses were used. The
BRIEF GEC was a significant predictor of adaptive functioning across domains with greater
executive dysfunction associated with reduced adaptive functioning (see Table 11). The BRIEF
GEC was uniquely able to explain 45%, 26%, and 39% of the variance across the three
domains. Learning Slope from the CVLT-C was a significant predictor on the Conceptual and
Practical domains explaining 6% and 3% of the variance respectively, and was positively related
to adaptive functioning. The overall model was able to explain 55%, 28%, and 48% of the
variance across the Conceptual, Social, and Practical domains respectively.
Hypothesis 2: Behavior problems (BASC-2 Internalizing and Externalizing Problems) at
Time 1 were predicted to be negatively associated with independent living skills at Time 2.
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Table 10. Unstandardized b coefficients (standard error) showing the ability of seizure variables
to predict the three domains of the ABAS-II.

Conceptual

Social

Practical

.08 (.06)

.07 (.06)

.06 (.07)

-16.18 (5.94)**

-12.84 (5.95)*

-18.87 (7.05) **

Number of Current AEDs

-4.37 (4.75)

-1.60 (4.75)

2.79 (5.64)

Number of Past AEDs

1.43 (1.43)

-1.70 (1.43)

-1.77 (1.69)

Number of Seizure Types

-2.39 (2.52)

-.76 (2.53)

0.10 (3.00)

Temporal Lobe Surgery

-6.57 (6.50)

-9.48 (6.51)

-4.70 (7.72)

Age at Seizure Onset
Active Seizures

Note. Abbreviations: ABAS-II, Adaptive Behavior Assessment System 2nd Edition; AEDs, Antiepileptic Drugs.
* p(one-tailed) ≤ .05 **p(one-tailed) ≤ .01
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Figure 3.

Figure 3. Bar graph showing the differences in adaptive functioning according to whether
seizures are active (n = 26 ) or controlled (n = 20).
Note. Active seizures denotes whether or not a child has had one or more seizures in the last year. Abbreviations:
ABAS-II, Adaptive Behavior Assessment System 2nd Edition.
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Table 11. Unstandardized b coefficients (standard error) showing the ability of
neuropsychological variables to predict the three domains of the ABAS-II.

CVLT-C Trial1
CVLT-C Learning Slope
CVLT-C Long Delay Free Recall
BRIEF GEC

Conceptual

Social

Practical

-.06 (.15)

-.10 (.19)

.01 (.18)

-.31 (.11)**

-.16 (.14)

-.25 (.14)*

.15 (.10)

.04 (.12)

.13 (.12)

-.62 (.08)**

-.46 (.10)**

-.64 (.10)**

Note. Abbreviations: ABAS-II, Adaptive Behavior Assessment System 2nd Edition; CVLT-C, California Verbal
Learning Test-Children’s Version; BRIEF, Behavior Rating Inventory of Executive Functioning; GEC, Global
Executive Composite.
* p(one-tailed) ≤ .05 **p(one-tailed) ≤ .01
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Linear regression analyses were used to determine the extent to which behavior problems were
able to predict adaptive functioning. Internalizing Problems significantly predicted the
Conceptual (b = -.31, SE = .14, p (one-tailed) = .02, r2 = .06), Social (b = -.32, SE = .14, p (onetailed) = .01, r2 = .07), and Practical (b = -.35, SE = .16, p (one-tailed) = .02, r2 = .06) domains.
Similarly, Externalizing Problems significantly predicted the Conceptual (b = -.38, SE = .15, p
(one-tailed) = .01, r2 = .08), Social (b = -.31, SE = .15, p (one-tailed) = .02, r2 = .06), and
Practical (b = -.37, SE = .17, p (one-tailed) = .02, r2 =.06) domains. Overall, the model was able
to explain 27%, 24%, and 24% of the variance respectively.
Hypothesis 3: Based on the results of hypotheses 1 and 2, verbal learning (CVLT-C
Learning Slope), executive functioning (BRIEF GEC), and behavior problems (BASC-2 Behavior
Problems Composite) at Time 1 were predicted to mediate the relationship between SHS scores
at Time 1 and adaptive functioning at Time 2 (see Figure 1a). Furthermore, this relationship was
hypothesized to persist when neuropsychological functioning and SHS scores at Time 2 (both
when SHS scores at Time 1 were controlled for and when SHS scores were not controlled for)
were used (see Figure 1b).
In light of the large number of potential mediational models (18) and the resulting
increased risk of finding an effect purely by chance, the decision was made to test each
proposed meditational model with the General Adaptive Composite (GAC) of the ABAS-II as the
dependent variable first. If a significant indirect effect was found, the model was then tested
with each of the three domains. If no significant indirect effect was found, testing of that model
was discontinued. Prior to testing the significance of the indirect effect, the correlations between
the independent variable and the mediators were examined (see Table 7). Learning Slope was
found to be non-significantly correlated with SHS (r = -.01), and, therefore, was dropped from
the model. Owing to the significant correlation between Externalizing and Internalizing
Problems of the BASC-2 (r = .48, p(one-tailed) < .001 at Time 1 and r = .44, p(one-tailed) < .001
at Time 2), the decision was made to combine the two scales into a Behavior Problems
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Composite when testing for mediation to reduce the likelihood of suppression: the indirect
effects remained non-significant when both scales were entered as mediators, but there was
evidence of suppression as the relationships between some variables were in the direction
opposite to previous research of these constructs. In light of greater theoretical interest in
examining the independent contributions of measures of executive functioning and behavior
problems in explaining the relationship between seizure history and adaptive functioning and the
high correlations between the BASC-2 and the BRIEF, the decision was made to examine the
significance of the indirect effects of executive functioning while controlling for behavior
problems and vice versa.
Controlling for behavior problems, the c pathway, or total effect, between SHS scores at
Time 1 and the ABAS-II GAC and three adaptive domains was significant (see Table 12), but
when the mediator, executive functioning at Time 1, was introduced, SHS scores dropped from
significance (c’). The ab pathway was significant with 95% confidence intervals that indicated
that the coefficient for this pathway was significantly different from zero. Thus, there was full
mediation of the relationship between SHS scores at Time 1 and adaptive functioning at Time 2
by executive functioning at Time 1. Similarly, when the model was re-run with SHS scores and
executive functioning at Time 2, the ab pathway was significant, indicating full mediation of the
relationship between SHS scores and adaptive functioning by executive functioning at Time 2.
Mediation was not evident, however, for the Social domain, as there was not a notable change
from c to c’ when executive functioning was entered into the model. The model was also run
controlling for SHS scores at Time 1, in order to test whether the relationship between changes
in SHS scores and adaptive functioning was also mediated by executive functioning. For this
model, partial mediation was evident for both the ABAS-II GAC and the Practical domain. Partial
mediation occurs when there is a drop from c to c’, but c’ prime continues to be significant. Full
mediation was found for the conceptual domain. Behavior problems were not found to mediate
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Table 12. Coefficients (standard errors) for mediation with the Seizure History Scale (SHS) as the Independent Variable at either
Time 1 or Time 2 (both when Time 1 scores on the SHS are controlled for and when they were not).

Time

1

Mediator

DV

a

b

c

c'

ab

Confidence
Intervals for
ab

GAC

.76 (.35)*

-.59 (.16)**

-.86 (.46)*

-.41 (.43)

-.44 (.20)

-.87 to -.09

Conceptual

.76 (.35)*

-.59 (.14)**

-.96 (.43)*

-.50 (.39)

-.45 (.19)

-.85 to -.11

Social

.76 (.35)*

-.26 (.16)

-.65 (.44)

-.46 (.45)

-.18 (.12)

-.58 to -.03

Practical

.76 (.35)*

-.76 (.35)*

-.66 (.51)

-.12 (.46)

-.55 (.26)

-1.11 to -.09

GAC

.02 (.24)

.00 (.22)

-.48 (.40)

-.48 (.40)

.00

-.12 to .11

GAC

.87 (.29)**

-.55 (.18)**

-1.12 (.41)**

-.64 (.41)

-.48 (.23)

-1.07 to -.13

Conceptual

.87 (.28)**

-.63 (.16)**

-1.16 (.40)**

-.61 (.38)

-.55 (.23)

-1.12 to -.19

Social

.87 (.28)*

-.12 (.17)

-.84 (.37)*

-.73 (.40)*

-.10 (.16)

-.49 to .15

Practical

.87 (.29)**

-.67 (.20)**

-1.01 (.47)*

-.43 (.47)

-.59 (.29)

-1.34 to -.16

GAC

-.06 (.23)

-.03 (.23)

-.53 (.39)

-.53 (.40)

.00 (.06)

-.11 to .13

GAC

1.10 (.52)*

-.53 (.18)**

-1.94 (.73)**

-1.35 (.71)*

-.59 (.33)

-1.46 to -.12

BRIEF

BASC-2

2

BRIEF

BASC-2

2 controlling for
Time 1

BRIEF
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Time

2 controlling for
Time 1

Mediator

DV

a

b

c

c'

ab

Confidence
Intervals for
ab

Conceptual

1.10 (.52)*

-.62 (.16)**

-.1.75 (.71)*

-1.06 (.66)

-.68 (.32)

-1.53 to -.20

Social

1.10 (.52)*

-.11 (.17)

-1.57 (.66)**

-1.45 (.69)*

-.11 (.21)

-.67 to .22

Practical

1.10 (.52)*

-.65 (.20)**

-2.07 (.84)**

-1.36 (.80)*

-.74 (.41)

-1.81 to -.15

GAC

-.21 (.41)

-.05 (.23)

-1.25 (.70)*

-1.26 (.70)

.00 (.10)

-.14 to .28

BRIEF

BASC-2

Note. When the BRIEF was examined as a mediator, performance on the BASC-2 was controlled for, and when the BASC-2 was examined as a mediator,
performance on the BRIEF was controlled for. See Figures 1 and 2 for an illustration of pathways. Pathway a represents the path from SHS to BASC-2 or BRIEF.
Pathway b denotes the path between BASC-2 or BRIEF and adaptive functioning (Adaptive Behavior Assessment System-II GAC and domains). Pathway c
represents the path from SHS to adaptive functioning, while pathway c’ represents the pathway from SHS to adaptive functioning controlling for BASC-2 or BRIEF
scores. Pathway ab denotes the pathway from SHS to BASC-2 or BRIEF to adaptive functioning. Abbreviations: DV, Dependent Variable; BASC-2, Behavior
Assessment System for Children 2nd Edition; BRIEF, Behavior Rating Inventory of Executive Functioning; GEC, Global Executive Composite; GAC, General
Adaptive Composite.
*p (one-tailed) ≤ .05 **p (one-tailed) ≤ .01
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the relationship between SHS scores and adaptive functioning at either Time 1 or Time 2 (see
Table 12).
Hypothesis 4: Verbal learning (CVLT-C Learning Slope), executive functioning (BRIEF
GEC), and behavior problems (BASC-2 Behavior Problems Composite) at Time 1 were
predicted to mediate the relationship between Group at Time 1 and adaptive functioning at Time
2 (see Figure 2a). Furthermore, this relationship was hypothesized to persist when examining
neuropsychological functioning and Group at Time 2 (both when Group at Time 1 was controlled
for and when it was not; see Figure 2b).
As with hypothesis 3, each model was tested first with the ABAS-II GAC as the DV, and
only if the indirect effect was significant did testing of the model continue at the domain level.
Prior to testing the significance of the indirect effect, the correlations between the IV and the
mediators were examined. Learning Slope was found to be non-significantly correlated with
Group (r = .01), and, therefore, was dropped from the model. As with the above model, when
executive functioning was tested as a mediator, behavior problems were controlled for and vice
versa.
Controlling for behavior problems, the c pathway, or total effect, between group
membership at Time 1 and the ABAS-II GAC and Conceptual and Practical domains was
significant (see Table 13), but when the mediator, executive functioning at Time 1, was
introduced, this relationship (c’) dropped from significance (ABAS-II GAC and the Practical
domain) or remained significant but was substantially reduced in size (the Conceptual domain).
The ab pathway was significant with 95% confidence intervals that indicate that the coefficient
for this pathway was significantly different from zero. Thus, there was full mediation of the
relationship between Group at Time 1 and scores on the ABAS-II GAC and Practical domain at
Time 2 by executive functioning at Time 1. There was partial mediation of the relationship
between Group at Time 1 and scores on the Conceptual domain at Time 2 by executive
functioning at Time 1. Executive functioning at Time 2 did not mediate the relationship between
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Table 13. Coefficients (standard errors) for mediation with Group as the IV at either Time 1 or Time 2 (both when Time 1 group
membership is controlled for and when it was not).

Time

1

Mediator

DV

a

b

c

c'

ab

Confidence
Intervals for
ab

GAC

5.37 (2.14)**

-.55 (.16)**

-7.25 (2.77)**

-4.28 (2.66)

-2.90 (1.31)

-6.12 to -.84

Conceptual

5.37 (2.14)**

-.56 (.14)**

-7.72 (2.57)** -4.69 (2.41)*

-3.03 (1.32)

-6.10 to -.84

Social

5.37 (2.14)**

-.23 (.16)

-5.08 (2.69)*

-3.82 (2.80)

-1.11 (.99)

-4.26 to .03

Practical

5.37(2.14)**

-.67 (.17)**

-6.45 (3.06)*

-2.85 (2.87)

-3.52 (1.57)

-7.07 to -.89

GAC

-.67 (1.54)

-.02 (.22)

-4.54 (2.55)*

-4.56 (2.57)

.14 (.49)

-1.41 to .85

GAC

1.39 (1.39)

-.63 (.17)**

-2.37 (1.96)

-1.50 (1.78)

-.89 (.91)

-2.90 to .76

GAC

.35 (1.01)

-.01 (.23)

-1.51 (1.76)

-1.50 (1.77)

-.01 (.24)

-.63 to .43

GAC

-1.02 (1.89)

-.59 (.17)**

.84 (2.68)

.24 (2.46)

.64 (1.08)

-1.23 to 3.12

GAC

-.50 (1.37)

-.02 (.23)

-.12 (2.39)

-.11 (2.41)

.02 (.27)

-.77 to .44

BRIEF

BASC-2

2

BRIEF

BASC-2

2 controlling
for Time 1

BRIEF

BASC-2
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Note. Group at Time 1 represents whether the child belongs to the Typically Developing, Monotherapy, or Polytherapy group. Group at Time 2 represents whether
the child belongs to the Typically Developing, Monotherapy, Polytherapy, or Surgery group. When the BRIEF was examined as a mediator, performance on the
BASC-2 was controlled for, and when the BASC-2 was examined as a mediator, performance on the BRIEF was controlled for. See Figures 1 and 2 for an
illustration of pathways. Pathway a represents the path from Group to BASC-2 or BRIEF. Pathway b denotes the path between BASC-2 or BRIEF and adaptive
functioning (Adaptive Behavior Assessment System-II GAC and domains). Pathway c represents the path from Group to adaptive functioning, while pathway c’
represents the pathway from Group to adaptive functioning controlling for BASC-2 or BRIEF scores. Pathway ab denotes the pathway from Group to BASC-2 or
BRIEF to adaptive functioning. Abbreviations: DV, Dependent Variable; BASC-2, Behavior Assessment System for Children 2nd Edition; BRIEF, Behavior Rating
Inventory of Executive Functioning; GEC, Global Executive Composite; GAC, General Adaptive Composite.
*p(one-tailed) ≤ .05 **p(one-tailed) ≤ .01
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Group at Time 2 and adaptive functioning at Time 2 either when controlling for Group at Time 1
or when not controlling for prior group membership. Controlling for executive functioning,
behavior problems did not serve as a mediator of the relationship between group and adaptive
functioning at either Time 1 or Time 2 (see Table 13) suggesting the unique importance of
executive functioning.
Supplementary Analyses
A strong relationship was found between executive and adaptive functioning, with
executive functioning mediating the impact of seizure history on adaptive functioning. This
raised the question of whether this strong relationship between executive and adaptive
functioning was present only in typically developing children, only in children with epilepsy or
both. We hypothesized that the relationship between executive functioning and adaptive
functioning at both Times 1 and 2 would be moderated by an epilepsy variable indicating
whether or not the child had ever experienced a seizure such that the relationship between
adaptive and executive functioning would be stronger for children with epilepsy.
Prior to the creation of interaction terms, executive functioning was mean centered for
both Times 1 and 2 (Holmbeck, 2002). At Time 1, executive functioning (B = -.56, SE = .09, p
(one-tailed) < .001) was significantly associated with the ABAS-II GAC, but seizure status was
not (B = -6.68, SE = 4.56, p (one-tailed) = .08). The interaction term was not significant (B = .05, SE = .34, p (one-tailed) = .45). At Time 2, executive functioning (B = -.64, SE = .10, p (onetailed) < .001) was significantly associated with the ABAS-II GAC, but seizure status was not (B
= -2.99, SE = 4.56, p (one-tailed) = .27). The interaction term for this model was significant (B =
-.57, SE = .28, p (one-tailed) = .02; R2Δ = .04) with executive functioning better predicting
adaptive functioning for the children with epilepsy (B = -.73, SE = .11, p (one-tailed) < .001),
versus typically developing children (B = -.16, SE = .25, p (one-tailed) = .26). It should be noted
that higher scores on the BRIEF are indicative of more difficulties with executive functioning,
while higher adaptive scores indicate better adaptive functioning (see Figure 4).
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Figure 4.

Figure 4. Regression lines for the relationship between executive functioning and adaptive
functioning as moderated by whether children have epilepsy or are typically developing (a 2-way
interaction).
Note. Seizures b = -.73; Typically Developing b = -.16. Abbreviations: SD, standard deviation.
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In light of significantly higher intellectual functioning in the typically developing group as
compared to the children with epilepsy, the above models were re-run controlling for intellectual
functioning to confirm that the stronger relationship between executive and adaptive functioning
was not simply due to the lower level of functioning in children with epilepsy. The results were
similar. For Time 1, intellectual functioning was entered in step 1 and found to be significantly
predictive of the ABAS-II GAC (B = .49, SE = .12, p (one-tailed) < .001). Entered at step 2,
executive functioning (B = -.51, SE = .09, p (one-tailed) < .001) was significantly associated with
the ABAS-II GAC, but seizure status was not (B = -1.44, SE = 5.04, p (one-tailed) = .39). The
interaction term was not significant (B = .07, SE = .33, p (one-tailed) = .42). At Time 2,
intellectual functioning (B = -.64, SE = .10, p (one-tailed) < .001) and executive functioning (B =
-.59, SE = .11, p (one-tailed) < .001) were significantly associated with the ABAS-II GAC, but
seizure status was not (B = -.50, SE = 5.09, p (one-tailed) = .46). The interaction term for this
model was significant (B = -.54, SE = .27, p (one-tailed) = .03; R2Δ = .03) with executive
functioning better predicting adaptive functioning for the children with epilepsy (B = -.67, SE =
.11, p (one-tailed) < .001), versus typically developing children (B = -.13, SE = .25, p (one-tailed)
= .30).
Across measures, there was less variability in performance in the typically developing
group. To help clarify whether this reduced range was the reason for the finding of moderation,
this model was also tested with internalizing and externalizing behavior problems from the
BASC-2, which evidenced similar rates of variability compared to the BRIEF GEC. The
interaction terms for Internalizing (T1 B = -.49, SE = .61, p (one-tailed) = .22; T2 B = -.09, SE =
.46, p (one-tailed) = .43) and Externalizing (T1 B = .19, SE = .61, p (one-tailed) = .38; T2 B =
.001, SE = .40, p (one-tailed) = .50) Behavior Problems were not significant at either time point
indicating that the relationship between behavior problems and adaptive functioning did not
differ according to whether or not a child had been diagnosed with epilepsy.
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Given the predictive utility of the active seizures variable, we further hypothesized that
the relationship between executive and adaptive functioning would be stronger for children with
active seizures as they would be at greater risk of both executive and adaptive dysfunction as
compared to children with controlled seizures. At Time 1, executive functioning (B = -.56, SE =
.10, p (one-tailed) < .001) was significantly associated with the ABAS-II GAC, but the active
seizures variable was not (B = 8.47, SE = 9.42, p (one-tailed) = .19). The interaction term was
not significant (B = .19, SE = .45, p (one-tailed) = .35). At Time 2, executive functioning (B = .65, SE = .11, p (one-tailed) < .001) and the active seizures variable (B = -10.43, SE = 4.25, p
(one-tailed) = .01) were significantly associated with the ABAS-II GAC. The interaction term was
not significant (B = .30, SE = .22, p (one-tailed) = .10) indicating that the relationship between
executive and adaptive functioning is not altered by whether children have active or controlled
seizures.
Chapter 4
DISCUSSION
The overarching aim of this study was to identify the seizure, treatment, and
neuropsychological variables associated with adaptive functioning in children with epilepsy to
not only better characterize adaptive functioning in this population, but also to aid in the
identification of children with epilepsy at risk of suboptimal adaptive functioning. The findings
from the first specific aim suggest that more severe history of epilepsy, as evidenced by the
cumulative and interactive effects of active seizures, higher numbers of current and past AEDs,
more seizure types, and surgical intervention, is associated with reduced adaptive functioning.
With respect to the ability of specific seizure and treatment variables to predict adaptive
capabilities, this study showed that children who have had one or more seizures in the past year
are at greater risk of suboptimal adaptive functioning according to parent-report. Inconsistent
with what was hypothesized, and somewhat surprisingly, no other specific seizure and
treatment variables were significantly associated with adaptive functioning.
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The findings from the second specific aim indicate that verbal learning, behavior
problems, and executive functioning were significant neuropsychological predictors of later
adaptive functioning. Executive functioning and behavior problems were tested as mediators of
the relationship between seizure severity and adaptive functioning. Mediation was confirmed for
executive functioning only, suggesting that seizure severity affects executive functioning
abilities, which, in turn, affect adaptive skills. This means that children with a more severe
history of epilepsy are at greater risk of executive deficits, and that more executive dysfunction
places children at greater risk of adaptive deficits. A further hypothesis postulated that executive
functioning and behavior problems would mediate the relationship between group membership
and adaptive functioning. This hypothesis was only supported for executive functioning at Time
1 mediating the relationship between group at Time 1 and adaptive functioning at Time 2. This
indicated that group membership has a weaker influence on executive functioning abilities than
seizure severity, and may be a reflection of the grouping variable being a poor way of classifying
seizure status. This finding also may indicate the greater importance of seizure status over
treatment (i.e., monotherapy, polytherapy) group.
Forty-four percent of eligible families participated in this study, and this sample of 62
was, for the most part, representative of the larger pool of potential participants. There were,
however, some significant differences at Time 1 between children who participated and those
who did not. Children treated with monotherapy who participated in the study were more likely to
have active seizures and fewer executive problems, than children who did not. Children who
were treated with polytherapy and participated in the study had a significantly younger age at
seizure onset than those who did not participate. Among typically developing children, those
who participated in the study had more externalizing and executive difficulties than those who
did not, but mean scores for both groups on these measures remained within normal limits.
Overall, this indicates that the families who participated in this study were a representative
sample, however, the higher incidence of active seizures at Time 1 for monotherapy participants
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and the earlier age at seizure onset for polytherapy participants suggests that children with
more severe epilepsy histories may have been more likely to participate. Nevertheless, there
were no significant differences between those who participated and those who did not with
respect to IQ and performance on the CVLT-C, and minimal differences on the BASC-2 and
BRIEF suggesting similar levels of functioning regardless of participation status.
Among those who participated, significant between group differences on some
demographic variables were noted. The surgery group was significantly older than the
monotherapy, polytherapy, and typically developing groups at the time the parent
questionnaires were completed. There was a significantly longer amount of time between
Times 1 and 2 for children in the monotherapy (M = 2.08, SD = .78 years) and surgery (M =
2.69, SD = 1.58 years) groups as compared to the polytherapy (M = 1.37, SD = .43 years) and
typically developing groups (M = 1.25, SD = .31 years). Although early surgical intervention for
intractable seizures is becoming increasingly popular, the older age of the surgery group likely
reflects the more prevalent view that surgery is a last-resort treatment (Sheth et al., 2000). Age
at seizure onset was significantly older for the surgery group compared to the typically
developing group, with children in the surgery group having their first seizure when they were
approximately 4 years older than children in the polytherapy group. Nevertheless, the duration
of epilepsy was similar across all three groups: monotherapy (M = 7.69 years, SD = 4.13),
polytherapy (M = 8.34 years, SD = 3.84), and surgery (M = 6.94 years, SD = 5.31).
Socioeconomic status (SES) was significantly greater for the typically developing group
compared to the monotherapy and surgery groups, however, mean SES was above the
midpoint of the scale for all groups. The surgery group was comprised of significantly more
Caucasians than African Americans compared to the typically developing group. This may
result from a number of potential factors including hospital demographics and racial disparities
in access to healthcare, healthcare information, and parent advocacy regarding their child’s
treatment. Participants in the polytherapy group were significantly more likely to be left-handed
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than typically developing children, which may reflect greater neurological disruption and/or
reorganization in this group. Finally, all three epilepsy groups were more likely to have an
Individualized Education Plan in place compared to the typically developing group. This is
consistent with research showing that children with epilepsy are at risk of reduced academic
achievement (Bailet & Turk, 2000; Caplan et al., 2004; Tromp et al., 2004). Overall, these
demographic differences are likely to reflect real differences between groups on these variables.
Consistent with other studies examining adaptive functioning in epilepsy (Chapieski et
al., 2005; Culhane-Shelburne et al., 2002), children with epilepsy in this study were found to be
functioning in the lower end of the average to the low average range overall with respect to the
mastery of age-appropriate independent living skills. Between one third and three quarters of
children with epilepsy were functioning below the 25th percentile on adaptive functioning
domains, suggesting that while mean scores are not that poor, a significant percentage of
children are functioning below the average range. For the typically developing group,
performance was in the average range across domains, with 25% or fewer children functioning
below the 25th percentile across domains. At the domain level, there was a weak trend for
children across both the epilepsy and typically developing groups to be functioning at a lower
level relative to normative data on the ABAS-II Practical Domain, which includes skills such as
folding clean clothes, calling for help if someone is hurt, and tying one’s shoes.
Verbal learning and memory as well as auditory attention were assessed at Time 1 and
were found to be in the average to low average range across epilepsy groups. Between 30%
and 60% of children in the monotherapy and polytherapy groups were functioning below the 25th
percentile on these measures. Verbal learning and memory as well as auditory attention were
within the average range for the typically developing group. Between 13% and 31% were
functioning below the 25th percentile in the typically developing group with the greatest
percentage of children performing below average on verbal learning. From Time 1 to Time 2,
there was a trend for increasing executive dysfunction, and, at Time 2, children with seizures
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were, overall, one standard deviation above the mean indicative of greater executive difficulties.
Ratings of behavior problems remained fairly consistent over time in the children with epilepsy,
with externalizing and internalizing problems equally as common and slightly elevated relative to
norms, but not in the clinically significant range overall. Nevertheless, approximately one third of
children with epilepsy were above the 25th percentile indicative of more behavior problems, as
compared to fewer than 25% of typically developing children. For the typically developing group,
mean ratings of behavior problems and executive functioning were within normal limits at both
Times 1 and 2. Although intellectual functioning was only assessed at Time 1, IQ scores were
generally commensurate with adaptive functioning abilities at Time 2 for children with epilepsy,
with 35% of children in the monotherapy group and 57% of children in the polytherapy group
functioning below the 25th percentile. Intellectual functioning for the typically developing group
was in the high average range with no children performing below the 25th percentile, and their
adaptive functioning, assessed at Time 2, was in the average range across domains and the
ABAS-II GAC, suggesting that adaptive skills were somewhat weaker than intellectual
functioning.
No significant between group differences on neuropsychological functioning were found
between the epilepsy groups at either Time 1 or Time 2. This suggests that, as a whole,
children are not performing significantly differently according to a broad measure of their
epilepsy status (monotherapy, polytherapy, surgery), and raises questions about the utility of
grouping children in this way. Significant between group differences were observed between the
typically developing group and epilepsy groups. At Time 1, children on monotherapy and
polytherapy were found to display significantly more internalizing problems (BASC-2) and more
executive problems (BRIEF; monotherapy: BRI, polytherapy: GEC, BRI, and MI) than children in
the typically developing group. Children in both the monotherapy and polytherapy groups were
found to have significantly poorer attention (CVLT-C Trial 1), memory (CVLT-C Long Delay Free
Recall), and intellectual functioning (Wechsler Full Scale IQ) compared to typically developing
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children. Although IQ was assessed at Time 1, and adaptive functioning at Time 2, these
abilities were generally commensurate, and when controlling for IQ, there were no significant
differences in adaptive functioning across groups. This is consistent with the typically reported
moderate correlations between IQ and adaptive functioning, and attests to the lower level of
functioning in children with epilepsy compared with typically developing children.
At Time 2, no differences were observed between the epilepsy groups. Children on both
monotherapy and polytherapy were found to be displaying significantly more internalizing
problems (BASC-2) and executive dysfunction (BRIEF GEC, BRI, and MI) and significantly
poorer adaptive functioning (ABAS-II GAC and Conceptual and Practical domains) compared to
typically developing children. Children in the surgery group differed from the typically
developing group on a component of executive functioning (BRIEF BRI) and with respect to
overall adaptive functioning (ABAS-II GAC). The lack of more significant differences between
the surgery and typically developing groups is likely due to the higher standard deviations for
the surgery group indicative of greater variability in functioning in this group. The prevalence of
significant differences between children in the typically developing group compared to children
with epilepsy is consistent with other studies reporting neurocognitive and behavioral difficulties
in children with epilepsy (Adams et al., 2002; Bailet & Turk, 2000; Caplan et al., 2004;
Prahbhjoy & Pratibha, 2005; Williams et al., 1998a).
Specific Aim 1
Consistent with what was hypothesized, more severe epilepsy history was significantly
associated with reduced adaptive functioning across domains. This finding expands upon
previous research, which has shown that more severe epilepsy is associated with poorer
cognitive functioning including in the areas of intellectual functioning and academic achievement
(Bailet & Turk, 2000; Caplan et al., 2004; Lah, 2004; Tromp et al., 2004), by providing evidence
that the deleterious effects of more severe epilepsy extend to adaptive functioning as well. This
result also supported the utility of using a measure of cumulative seizure history in predicting
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outcome in children with epilepsy. This measure, however, was not able to explain as much
variance in adaptive functioning as a conglomeration of individual seizure and treatment
variables.
The extent to which specific seizure and treatment variables were related to adaptive
functioning also was tested. The results indicated that the relationship between the active
seizure variable and adaptive functioning was strong and present across adaptive domains.
Children with active seizures were shown to be functioning at a lower adaptive level than their
healthy peers as well as their peers with controlled seizures. As illustrated in Figure 3, in the
controlled seizure group, adaptive functioning was consistently in the average range overall. In
the active seizure group, adaptive functioning ranged from the low end of the low average range
to the borderline range. This suggests that there is a strong association between active seizures
and suboptimal adaptive functioning.
At Time 1, 43 of 46 children had active seizures, while at Time 2, 26 children had active
seizures. This indicates that a significant proportion of children are likely to attain seizure control
over time. Adaptive functioning appears to be at greater risk for those children who do not
attain seizure control over time, and may indicate a more severe course of epilepsy and
potentially an associated risk of poorer neuropsychological development. Consistent with what
would be expected, children in the polytherapy group were significantly more likely than children
in either the monotherapy or surgery groups to have active seizures, suggesting that this group
may be particularly vulnerable to adaptive deficits. Furthermore, this group had a higher
percentage of children who were functioning below the 25th percentile across both the
Conceptual and Practical domains, but not the Social domain, compared to the monotherapy
and surgery groups.
The lack of significant predictive utility for the remaining seizure and treatment variables
was surprising, but suggests that they may contribute little additional variance to understanding
adaptive functioning in this population. Specific seizure and treatment variables have been
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found to be predictive of other outcome variables in different studies, and the lack of findings
here may be due to the heterogeneity of this sample, which did not exclusively examine children
with a specific site of seizure focus (e.g., left temporal), with a specific type of seizure (e.g.,
complex partial), or children who belonged to a specific subgroup (e.g., children with new-onset
epilepsy). Thus the variability in our sample’s epilepsy history may have favored a cumulative
measure of seizure severity over individual variables. It also is possible that specific seizure
and treatment variables, such as age at diagnosis, which have been shown to significantly
impact other domains of neuropsychological functioning, may not be as strongly associated with
performance on measures of adaptive functioning. This may be related to the acquisition of new
adaptive skills being less dependent on the mastery of prior adaptive skills (which is in contrast
to measures of, for example, of intellectual functioning or academic achievement). More
specifically, being able to make your own bed is a developmentally more demanding adaptive
task compared to picking up and throwing away trash or paper at home, but being able to
perform the latter is not contingent on the former. In contrast, being able to subtract using
double digits is likely to be dependent on the ability to successfully subtract using single digits.
This lack of a hierarchical relationship may mean that age at diagnosis has less of a clear effect
on the acquisition of adaptive skills over time. With the remaining seizure and treatment
variables entered into the model (number of past and present AEDs, number of seizure types,
and surgery), it is possible that they were proxy measures of epilepsy severity and the potential
for associated neurological dysfunction. The active seizures variable may have been the most
direct assessment of this underlying neurological dysfunction, and may explain its stronger
association with adaptive functioning. Additionally, adaptive behaviors require the integration of
more basic cognitive processes, and because of this complexity, cumulative measures of
seizure severity may be better able to account for adaptive outcome than single seizure
variables excluding the active seizures variable, which was significantly predictive of adaptive
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functioning across domains. More studies are needed to both confirm and extend the
association between active seizures and adaptive functioning.
Reduced adaptive functioning in children with active seizures may be a result of a
combination of both environmental and neurological factors. With respect to environmental
factors, it is possible that parents place greater restrictions on their child’s independence while
they continue to have seizures to ensure their child’s safety and well-being. Additionally,
children who continue to have seizures may be more socially isolated as a result of
stigmatization (Adams et al., 2002), resulting in reduced opportunities to develop ageappropriate independent living skills. With respect to neurological factors, the brain’s continued
abnormal functioning as evidenced by persistent seizures and the potential for continued interictal disturbance may be interfering with the development of children’s adaptive skills and/or
their ability to evidence adaptive behavior in age-appropriate circumstances. Furthermore, the
active seizures variable was positively correlated with the number of AEDs a child was taking (r
= .44, p < .01), suggesting a potentially confounding effect of AEDs and their side effects or
possibly the medically refractory nature of some seizures to multiple medications. Although the
results of this study do not allow for a clear determination of the degree of influence of these
potential environmental and neurological factors, children with active seizures were significantly
more likely to have an Individualized Education Plan (IEP) in place at school than children with
controlled seizures (65% versus 17%). The greater prevalence of IEPs may be a marker of
more pervasive neurological dysfunction or disruption in children with active seizures.
The predictive utility of this active seizure variable warrants attention, particularly as
researchers are challenging the accuracy of patient report of seizure frequency (e.g., Hoppe &
Elger, 2007). While no studies could be found that examined the accuracy of parent report of
children’s seizure frequency, many parents reported that they had difficulty calculating anything
more than a broad estimate of seizure frequency (e.g., whether or not their child was having one
or more seizures a month). This was a particular issue when children experienced absence or

97
nocturnal seizures or seizures at school. Parents were, however, able to report the specific date
of their child’s last known seizure allowing for the calculation of whether or not a child had one
or more seizures in the last year to be made with more confidence than a measure of seizure
frequency. The findings of this study suggest that categorizing seizures as active or controlled
may be a meaningful estimate of current seizure burden that is easier for parents to report than
frequency, and that this measure may be subject to less measurement error and increased
reliability.
Specific Aim 2
Consistent with what was hypothesized, executive functioning, verbal learning, and
internalizing and externalizing behavior problems were found to be significantly associated with
adaptive functioning. More specifically, we found that better executive functioning abilities and
verbal learning as well as fewer internalizing and externalizing behavior problems were
associated with better adaptive functioning. Contrary to what was hypothesized, significant
relationships were not found between attention or verbal memory and adaptive functioning. The
lack of significant relationships between adaptive functioning and attention and verbal memory
is surprising, and may be due to a number of factors. The lack of significant relationships may
be due to the specific measures used. Trial 1 of the CVLT-C is considered a supraspan
measure of attention, and this may not be the most ecologically valid measure of attentional
functioning. It also is possible that the cognitive processes assessed by these variables may be
too specific and, therefore, not as strongly associated with adaptive functioning as measure of
broader constructs such as executive functioning.
With respect to mediation, verbal learning was dropped from the model owing to nonsignificant correlations with both the Seizure History Scale (SHS) and group membership. In
light of significant correlations between executive functioning and behavior problems, when
executive functioning was tested as a mediator, behavior problems were controlled for and vice

98
versa to allow for the examination of the specific contributions each variable could make to
understanding the relationship between epilepsy and adaptive functioning.
Mediation
Executive functioning at Time 1 fully mediated the relationship between scores on the
SHS at Time 1 and adaptive functioning at Time 2 across domains and the ABAS-II GAC. Full
mediation also was evident when executive functioning and SHS scores from Time 2 were used
for the ABAS-II GAC and the Conceptual and Practical domains, but not the Social domain. Full
mediation occurs when the relationship between the IV and DV becomes non-significant when
the mediator is entered into the model. The coefficient for the ab pathway, or indirect effect, was
significantly different from zero based on 95% confidence intervals, meaning that SHS scores
can best explain adaptive functioning through their effect on executive functioning. Thus, more
severe seizure history is associated with more executive dysfunction, which, in turn, is
associated with reduced adaptive functioning. This means that children with higher scores on
the SHS, indicative of a more severe seizure history, are at greater risk for deficits in executive
functioning, and these deficits in executive functioning are, successively, associated with
suboptimal adaptive functioning. Based on these findings, children with more severe epilepsy
history should be monitored closely for both executive and adaptive functioning issues.
The above model was re-run when SHS scores at Time 1 also were controlled for in
order to examine whether the change in cumulative seizure history from Time 1 to Time 2 was
predictive of adaptive functioning, and if this relationship was mediated by executive functioning.
Partial mediation was found for the ABAS-II GAC and the Practical domain. Partial mediation
occurs when there is a weakening in the relationship between the IV and DV, but it is still
significant. The presence of partial mediation here means that changes in seizure severity from
Time 1 to Time 2 are associated with adaptive functioning, and that this effect is partially
explained by the influence these changes in severity have on executive functioning. In other
words, executive functioning was partially, but not fully, able to explain the association between
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changes in seizure severity and adaptive functioning as measured by the ABAS-II GAC and the
Practical domain. This might mean that adaptive functioning is more susceptible to changes in
seizure severity than executive functioning. If there findings were confirmed, it might point to
adaptive functioning being more amenable to change, and therefore, more responsive to
interventions. The relationship between performance on the Conceptual domain and changes in
cumulative seizure history was found to be fully mediated by executive functioning, suggesting
that performance on this domain may be more susceptible to executive difficulties associated
with changes in seizure status.
Issues with Using Group Membership to Denote Epilepsy Severity
Mediation was more elusive when testing the model with group membership as the IV.
The relationship between Group at Time 1 and adaptive functioning at Time 2, was found to be
fully mediated by executive functioning at Time 1 for the ABAS-II GAC and the Practical domain,
and partially mediated for the Conceptual domain. At Time 2, executive functioning was not
able to mediate the relationship between Group and adaptive functioning whether group
membership at Time 1 was controlled for or not. The lack of mediation may be related to the
addition of a surgery group at Time 2. These results indicate that grouping children according to
their current treatment status may sometimes, but infrequently, be an appropriate method of
denoting epilepsy severity. At time 1, children in the polytherapy group performed, as a whole,
more poorly than the monotherapy group, who, in turn, performed more poorly that the typically
developing group on many neuropsychological measures. This hierarchical relationship is likely
what accounted for the finding of mediation by executive functioning at Time 1 because there
was a clearer, ordinal relationship between group membership and degree of impairment.
However, this linear relationship did not appear to hold at Time 2 when children who had
undergone temporal lobectomies for seizure control were designated as the fourth group. This
is likely because there was a great deal more heterogeneity in seizure severity within this group
that included children with a long-standing history of intractable epilepsy and children who
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underwent a surgical resection of a brain tumor within a short period of time from their first
documented seizure.
Additionally, problematic for examining functioning according to group membership was
that there did not appear to be a clear relationship between group membership and adaptive
functioning. Instead, all three seizure groups performed similarly suggesting that group
membership alone is not able to explain variability in adaptive performance. Thus, although it is
more traditional to place children in groups for ease of comparison, considering group
membership as an ordinal variable does not appear to be an appropriate way of studying the
effects of epilepsy in children. Instead, the scale developed in this study to examine cumulative
seizure history, the SHS, seemed to better capture the relationship between epilepsy,
neuropsychological functioning, and adaptive functioning.
Across meditational models, behavior problems did not mediate the relationship between
SHS scores or Group and adaptive functioning once executive functioning was controlled for.
Although behavior problems were significantly predictive of adaptive functioning, this effect was
no longer apparent when executive functioning was also part of the model. It seems that the
overlapping variance between behavior problems and executive functioning was what
accounted for the predictive utility of behavior problems, but that only the BRIEF General
Executive Composite (GEC) was able to contribute additional, unique, variance towards
explaining adaptive capabilities.
Supplementary Analyses
Supplementary analyses were designed to examine whether the strong relationship
observed between executive and adaptive functioning is a normal part of development or further
evidence of disrupted development in children with epilepsy. Moderation was not found when
examining the relationship between executive functioning at Time 1 and adaptive functioning at
Time 2. This means that the ability of executive functioning to predict later adaptive functioning
was not significantly different according to whether a child had epilepsy or not. The relationship
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at Time 2, however, between executive and adaptive functioning was found to be moderated by
whether or not a child had experienced seizures. In light of the significant difference in
intellectual functioning between the typically developing children and those who had
experienced seizures, this model was also tested when intellectual functioning was controlled
for to ensure that the observed relationship between executive and adaptive functioning in
children with epilepsy was not a product of their lower intellectual functioning. The interaction
persisted when intellectual functioning was controlled for, suggesting that this was not the case
and that the relationship between executive and adaptive functioning was stronger in children
with epilepsy than typically developing children regardless of intellectual ability. We further
examined whether the relationship between executive and adaptive functioning abilities would
be stronger for children with active seizures compared to children with controlled seizures.
Moderation was not found at either Time 1 or Time 2, suggesting that the relationship between
executive and adaptive functioning was not altered by current seizure status.
Across measures, there was less variability in performance for children in the typically
developing group. In order to better determine whether the observed interaction between
executive and adaptive functioning was related to differing levels of variability in performance
across children who have epilepsy compared to those who did not, moderation was also tested
using Internalizing and Externalizing Behavior Problems of the BASC-2, which evidenced similar
levels of variability to the BRIEF GEC. An interaction was not found at either Times 1 or 2. This
suggested that the observed interaction between executive and adaptive functioning is not
simply a byproduct of differing levels of variability. Nevertheless, confirmation of the presence
of this interaction with a typically developing sample with more variability in adaptive
performance is warranted.
Thus, concurrent executive and adaptive functioning appear to be much more closely
intertwined in children with epilepsy, regardless of whether seizures were active or controlled,
compared to typically developing children. This more highly correlated relationship between
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executive and adaptive functioning also has been shown in children with autism (Gilotty et al.,
2002) and children with a history of traumatic brain injury (Mangeot et al., 2002) suggesting that
it may not be unique to children with epilepsy, and instead may be apparent across pediatric
clinical populations. The observed association between adaptive and executive functioning may
be, in part, related to the design of both measures which seek to assess children’s day-to-day
functioning as opposed to measures which test a child’s maximal level of functioning in an
environment with minimal distractions. There is also likely to be overlap in the demands of
adaptive or executive tasks as both are dependent on the ability to respond appropriately to new
environments and tasks.
There was only a weak relationship between adaptive and executive functioning within
the typically developing group. Among children with seizures, however, there was a much
steeper slope with higher adaptive performance strongly associated with fewer executive
problems (i.e., lower scores on the BRIEF) and lower adaptive performance strongly associated
with more executive problems (higher scores on the BRIEF). This finding underscores the
importance of using control groups in clinical research. Having a typically developing
comparison group in this study allowed for the testing of how the observed relationship between
executive and adaptive functioning differed in typically developing children and children with
epilepsy. A better understanding of how cognitive development is altered by epilepsy is
important, not only for increasing our understanding of pediatric epilepsy, but also to help
clinicians develop and refine the most effective interventions. Overall, these results suggest a
significant concurrent association between adaptive and executive functioning in children with
epilepsy that may not be present in typically developing children.
There are limitations to using a parent-report measure to predict another parent-report
measure (e.g., shared variance). The BASC-2, however, is also a parent-report measure and
did not demonstrate the same utility as the BRIEF in predicting adaptive functioning, which
suggests that there are more to the findings of this study than simply parents completing both
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the BRIEF and ABAS-II. Additionally, research has shown correlations between the BRIEF and
a widely used objective, laboratory measure of executive functioning, the Delis-Kaplan
Executive Function System (D-KEFS), in children with epilepsy (Parrish et al., 2007).
Furthermore, among objective, laboratory measures of attention, verbal memory, nonverbal
memory, and executive functioning, measures of executive functioning were found to be the
strongest correlates of adaptive functioning (Culhane-Shelburne et al., 2002). Additionally, the
ecological validity of parent-report measures of executive functioning is asserted to be greater
than objective, laboratory measures of executive functioning, as the BRIEF is based on realworld, as opposed to laboratory, functioning. Thus, although there are some limitations to
parent-report measures, there are also benefits and the BRIEF has been shown to correlate
highly with objective, laboratory measures of executive functioning suggesting substantial
overlap across methodologies for assessing executive functioning.
Although a strong relationship between executive and adaptive functioning was
observed for children with epilepsy as compared to typically developing children, it is possible
that there may be alternate explanations for this finding. The lack of sufficient variability in
performance within the typically developing group may have been responsible for the weak
relationship observed between executive and adaptive functioning in typically developing
children. Although moderation was not found for the relationship with behavior problems, which
had similar rates of variability to the BRIEF GEC, and adaptive functioning, it remains possible
that the lack of variability in adaptive functioning in typically developing children may have
accounted for the weak relationship between executive and adaptive functioning in this group.
Future research will be needed to confirm if there is a stronger relationship between adaptive
and executive functioning in children with epilepsy.
Remediation of Adaptive Functioning Deficits
The findings of this study suggest that a subset of children with epilepsy are at risk of
significant adaptive impairments, and that this risk is associated with continued seizures and
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executive dysfunction. In fact, 57% of children with epilepsy in this study were performing at or
below the 25th percentile with respect to overall adaptive functioning compared to only 13% of
the children in the typically developing group. Furthermore, for children with intractable seizures,
research has shown significant declines in adaptive functioning over time (Berg et al., 2004),
thereby bolstering the need for remediation. With the potential to identify children at risk of
suboptimal adaptive functioning, comes the responsibility to find ways to boost adaptive
functioning for these children. Based on the findings of this study, complete seizure control
appears to be necessary for optimal adaptive development, and may be the first step in
reducing the likelihood that children will evidence adaptive deficits. For children displaying
adaptive deficits, interventions could be aimed at directly addressing adaptive deficits or
indirectly addressing them through remediating other cognitive functions, such as executive
functioning, that adaptive skills may be reliant on.
Within the realm of directly addressing adaptive deficits, there is new evidence to
suggest that attending an epilepsy-specific overnight camp can produce not only more adaptive
behaviors but also improve social interactions in children with epilepsy from ages 7 to 17
(Cushner-Weinstein et al., 2007). This study found that adaptive skills increased over the course
of the weeklong camp experience and that attending the camp the following year was able to
build upon those initial gains. There was not a no treatment group, rather all campers were
assessed both at the start and finish of the camp. These findings are preliminary, but promising,
with the authors describing the camp experience as a time for empowerment and inclusion for
children with epilepsy (Cushner-Weinstein et al., 2007). More research into the potential utility
of epilepsy camps in bolstering adaptive functioning is needed particularly as children did not
appear to maintain these gains over the course of the subsequent year, which may be the result
of the short duration of the camp (one week) being insufficient for creating lasting change or
result from bias in pre- and post-camp adaptive assessments.
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The existence of moderation of the relationship between executive and adaptive
functioning by seizure status, indicates that remediation of executive skills might be another
potential avenue through which to raise adaptive skills. This would seem a particularly fruitful
approach to study, in light of the widely reported findings of executive dysfunction in children
with epilepsy (Culhane-Shelburne et al., 2002; Parrish et al., 2007; Slick et al., 2006). Indeed,
studies have reported that executive functioning is a vulnerable domain of cognition even in
children with new-onset epilepsy whose seizures are well-controlled (Parrish et al., 2007) as
well as in a substantial subset of children with intractable epilepsy (Slick et al., 2006).
Furthermore, executive deficits may be apparent on both parent-report and neuropsychological
tests even in the absence of any impairment in intellectual functioning (Culhane-Shelburne et
al., 2002; Parrish et al., 2007). Culhane-Shelburne and colleagues (2002), for example, found
IQ to be in the average range, adaptive functioning to be in the low-average to borderline range,
and executive functioning to be in the average to low average range, suggesting that adaptive
deficits may be one of the most vulnerable domains of functioning in children with epilepsy.
Research on the success of executive function remediation strategies is sparse and
frequently limited to case-studies or small samples and lacking control groups. Meta-analyses
of studies have sought to extrapolate guidelines from these studies. For example, Kennedy and
colleagues (2008) reported evidence for improvements in executive functioning following
Metacognitive Strategy Instruction in adults with a Traumatic Brain Injury, but determined that
there was insufficient evidence to support the utility of specific remediation strategies in children
with a Traumatic Brain Injury, a finding echoed by Limond & Leeke (2005). No research studies,
however, could be found that examined the remediation of executive deficits in children with
epilepsy. This will be an important area of future research, not only to determine the most
efficacious ways to remediate executive functioning, but also to study whether there are
secondary gains in adaptive functioning following remediation of executive deficits.
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Limitations
This study is limited by its part retrospective nature which precluded us from having a
assessments of adaptive functioning at both Times 1 and 2. Without information about adaptive
functioning at Time 1, no commentary can be made about changes in adaptive functioning over
time or how adaptive functioning might change following surgical intervention. This study would
have benefited from the use of a broader neuropsychological battery that included objective
assessment of executive functioning, academic achievement, visual learning and memory,
working memory, and additional measures of attention. Additionally, our modest sample size
and the diversity in epilepsy history prevented the examination of whether and how seizure foci
might differentially affect adaptive functioning. In light of the variability in AEDs prescribed, this
study was unable to examine whether specific medications, particularly those more commonly
reported to have cognitive side effects such as Topamax, might differentially affect adaptive
functioning or the relationship between executive and adaptive functioning.
Although the use of a typically developing comparison group in this study allowed for
commentary on how relationships between variables differ in children with epilepsy as
compared to typically developing children, there were some limitations to the comparison group
used. Intellectually, this comparison group was functioning in the high average range overall.
Although mean performance on the other measures used in this study was in the average range
(CVLT-C, BASC-2, BRIEF, and ABAS-II), it would be beneficial to replicate these findings with a
sample of typically developing children functioning consistently in the average range.
Additionally, it would have been advantageous to have had a non-neurological chronic illness
comparison group (e.g., asthma) that had a similar range in severity (i.e., active versus
controlled) in order to control for the effects of frequent school absences and hospital stays.
Future Research
In light of the limited research on adaptive functioning in children with epilepsy, there are
numerous directions for potential research. These might include confirming the utility of the
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active seizures variable in explaining adaptive functioning, and testing whether this variable also
may be of use in explaining variance in other areas of neuropsychological functioning. A better
understanding of the underlying reason for the strong predictive utility of the active seizures
variable is warranted. There is some evidence that children with more severe epilepsy histories
may have been more likely to participate in this study, thus future studies may want to offer an
incentive, potentially financial, to encourage wider participation.
Future research also should seek to examine other aspects of neuropsychological
functioning (e.g., visual memory, processing speed, and motor skills) as well as more
comprehensive measures of constructs examined in this study (e.g., attention, memory,
executive functioning). This study used parent-report measures (ABAS-II, BASC-2, and BRIEF),
which have been shown to be advantageous as they offer a higher degree of ecological validity
than can be easily attained with direct assessment in testing conditions (Ris, 2007). Future
research should, however, examine whether objective, laboratory measures of the same
constructs produce similar results. With respect to the relationship between executive and
adaptive functioning, it will be important for future studies to confirm these findings both with
parent-report measures, as well as with teacher report and objective neuropsychological testing.
Should this relationship be shown to occur consistently in children with epilepsy, and differ from
that found in typically developing children or in children with other neurological disorders, the
clinical implications will need to be evaluated and greater attention paid to evaluating methods
for remediating both adaptive and executive functioning deficits. Additionally, longitudinal
studies will be of interest to further characterize how adaptive functioning trajectories are
influenced by seizures and their treatments over time. Such studies also could examine how
adaptive functioning trajectories might be altered by changes in epilepsy status and/or
treatments including epilepsy surgery.
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Conclusions
In spite of the aforementioned limitations, this study was able to provide more
clarification on the poorly understood adaptive functioning capabilities of children with seizures.
In particular, this study showed that adaptive functioning abilities were in the lower end of the
average to the low average range across domains for children with epilepsy. Cumulative seizure
history using the Seizure History Scale was able to significantly predict adaptive functioning
across domains. Additionally, whether or not a child had experienced one or more seizures in
the last year was best able to account for adaptive functioning compared to other individual
seizure and treatment variables. Of note, although no pre-surgical measure of adaptive
functioning was available, whether or not a child had undergone focal surgery was not found to
be significantly associated with adaptive functioning, suggesting that surgical intervention in and
of itself may not significantly affect adaptive functioning. Furthermore, children with active
seizures were shown to have adaptive functioning scores more than one standard deviation
below their peers with controlled seizures, suggesting that children who continue to experience
seizures, even if only as infrequently as once in the prior year, are still at risk of adaptive
deficits. Children with greater seizure burden are already known to be at greater risk of poorer
neurocognitive outcome, and this study extends those findings to include adaptive outcome.
This study also identified the best neuropsychological predictors of adaptive functioning,
which were found to be executive functioning, verbal learning, and internalizing and
externalizing behavior problems. Mediation was found, indicating that increased severity of
epilepsy history was associated with executive dysfunction which, in turn, was associated with
suboptimal adaptive functioning. To better examine the reported relationship between epilepsy
and adaptive functioning, the potential for moderation of this relationship by whether or not a
child had epilepsy was assessed. Moderation was found, and confirmed the presence of a
significantly stronger relationship between executive and adaptive functioning in children with
epilepsy, such that level of functioning in one area was strongly associated with level of
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functioning in the other. This relationship was not found in typically developing children. The
strength of this association in children with epilepsy coupled with research consistently reporting
that this population is at risk of executive deficits underscores the need for more research not
only into executive functioning, but also into adaptive functioning in children with epilepsy and
potential ways to reduce the risk of suboptimal functioning in these domains in children at risk.
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APPENDIX A
SEIZURE HISTORY SCALE

125
Seizure History Scale
ID # _________
________ Seizures in last 12 months
0
2
4
6

No
One-Four
Five-Ten
More than Ten

________ Seizure Types
0
1
2
3
4

Single Seizure Type
Two Seizure Types
Three Seizure Types
Four Seizure Types
Five or more Seizure Types

________ Status Epilepticus
0
1
2

Never
One-two times
Three or more times

________ Medication
0
1
2
3

Currently No Medication
Currently Monotherapy
Currently 2 Medications
Currently 3 or More Medications

________ Medication History
0
1
2
3
4
5

No past AEDS
1 Past AED
2 Past AEDs
3 Past AEDs
4 Past AEDs
5 or more past AEDs

________ Surgery
0
1
2

No Surgical Intervention
Removal of Brain Tumor
No evidence of tumor, removal of identified seizure focus

Total Score __________
Range = 0 - 22
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APPENDIX B

SEIZURE INFORMATION FORM SENT TO PARENTS FOR COMPLETION
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Seizure Information Form
Please complete and return in the enclosed envelope.
When was your child’s first seizure (Month/Day/Year)? ________________________________
When was your child’s most recent seizure (Month/Day/Year)? _________________________
What medication(s) is your child currently taking for epilepsy?
Name____________________________________ Dosage ____________________________
Name____________________________________ Dosage ____________________________
Name____________________________________ Dosage ____________________________
Name____________________________________ Dosage ____________________________
Has your child taken any other medications for epilepsy in the past? ______________________
____________________________________________________________________________
____________________________________________________________________________
When was your child’s last seizure medication change (Month/Day/Year)? This includes
changes in the kind or amount of seizure medication your child is taking. If there have not been
any changes, answer from the time your child was first prescribed seizure medication.
____________________________________________________________________________
Since your child’s most recent medication change, how many and what types of seizures has
your child had in the:
Examples: seizure type absence_______________ how many a month? 5_________________
seizure type tonic-clonic_____________ how many a month? 1_________________
First Month After Medication Change?
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
Two-6 Months After Medication Change?
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
7-12 Months After Medication Change?
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
13-24 Months After Medication Change?
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
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Please circle all types of seizures your child has had:
Tonic-Clonic/Grand Mal

Clonic

Tonic

Absence/Petit Mal

Atypical Absence

Spasms

Myoclonic

Simple Partial

Complex Partial

Eyelid Myolonia

Myoclonic Atonic

Negative Myoclonus

Atonic/Akinetic

Febrile

Focal Sensory

Focal Motor

Gelastic

Hemiclonic

Secondarily Generalized

Reflex

Nonepileptic

Status Epilepticus

Other, please specify:

_____________________________________________________

Is your child currently taking any other medication (not for seizure control)? ________________
____________________________________________________________________________
Has your child tried any other treatments for epilepsy (for example, ketogenic diet)?__________
____________________________________________________________________________
____________________________________________________________________________
Has your child had any significant medical issues since their last appointment at the Department
of Neuropsychology at Scottish Rite? If yes, please describe. ___________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
If your child has had surgery to help reduce seizures, what was the date of their surgery
(month/day/year)? _____________________________________________________________
If your child has had surgery to help reduce seizures: since having surgery, how many and what
types (e.g. absence, complex partial) of seizures did your child have in the:
First month after surgery?
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
Two-6 months after surgery
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
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7-12 months after surgery?
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
13-24 months after surgery?
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
Before having surgery, how many and what types (e.g. absence, complex partial) of seizures
did your child have in a typical:
Week?
seizure type__________________________how many a week? ___________________
seizure type__________________________how many a week? ___________________
seizure type__________________________how many a week? ___________________
Month?
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________
seizure type__________________________how many a month?__________________

Thank you!

